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ABSTRACT 
REACTIVE HETEROCYCLES FOR EXAMINING POLYKETIDE BIOSYNTHESIS 
SEPTEMBER 2013 
GITANJELI PRASAD, B.Tech., INSTITUTE OF CHEMICAL TECHNOLOGY 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Nathan A. Schnarr 
Polyketides are a class of natural products that exhibit remarkable structural and 
functionally diversity and are highly sought after due to their medicinally important activities. 
For many decades now, polyketide synthases (PKSs), the mega-enzymes responsible for 
biosynthesis of polyketides have been the focus of extensive investigation to make new 
polyketides by polyketide engineering strategies. While there are many established methods to 
investigate polyketide enzymes and biosynthesis mechanisms, they have substantial 
shortcomings that have limited the extent of success with polyketide engineering efforts.  
 This thesis focuses on developing simple, flexible yet powerful tools for examining 
polyketide biosynthesis by overcoming some deficiencies in currently used techniques. Reactive 
heterocylces have been designed for direct labeling of key polyketide synthase enzymes to 
provide a direct insight into its functions and mechanisms. First β-lactones and then β-lactams 
have been used as small molecule probes to perform site-specific labeling of acyl carrier 
proteins and further used for mechanistic interrogation of key steps in polyketide biosynthesis. 
The utility of these probes has been demonstrated by comparison to traditional probes and has 
been successfully applied to examine substrate selectivity of keto synthases, key enzymes in 
polyketide biosynthesis.  The applications of the tools described in this manuscript only scratch 
the surface of their capabilities and are expected to significantly aid in the study of new and 
vii 
 
existing PKS systems leading to improved understanding of how these extraordinary 
biosynthetic machines function. 
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CHAPTER 1 
 INTRODUCTION 
1.1. Polyketides and Polyketide synthases  
Polyketides are a diverse class of natural products found in soil and marine bacteria as 
well as fungi and higher plants.  In addition to exhibiting a large range of structural and 
functional diversity, they are a rich source of biologically active and medicinally relevant 
compounds. Despite the vast structural diversity observed in polyketides, their biosynthesis 
proceeds by simple, repetitive condensations of acetate or propionate type monomers in a 
manner that closely resembles mechanism of fatty acid synthases (FASs) 
1-3
. They are 
constructed by multi-enzyme assemblies termed as polyketide synthases (PKSs) that assemble 
simple acyl extender units in a linear fashion and yet this simple foundation is capable of 
producing molecules with enormous variation in structure and function.  Polyketides can be 
broadly classified into groups based on how their parent polyketide synthases function. Iterative 
PKSs use the same set of active sites to build a polyketide chain and perform processing on them 
to form aromatized or highly oxidized products. The same module repeatedly catalyzes chain 
elongation and modification. In contrast, modular PKSs consist of sequentially linked groups of 
active sites called modules to perform chain elongation and other transformations to give more 
reduced products that often undergo macrocyclization.   
1.1.1 Importance and Scope of PKSs 
A large number of polyketides have been used as commercial pharmaceutical products 
and include numerous antibiotics (e.g. erythromycin, tetracycline), anticancer agents (e.g. 
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doxorubicin, epothilone B), immunosuppressants (rapamycin), antifungal (e.g. amphotericin), 
cardiovascular agents (e.g. lovastatin) and veterinary products(e.g. tylosin) (Figure 1.). Over the 
past few decades, primarily due to their importance as pharmaceutical agents, polyketides have 
been the focus of extensive investigation
1,2
.  The prevailing problem of anti-bacterial resistance 
towards existing antibiotics has highlighted the need for new and effective therapies. There has 
been a troubling decline in emerging therapeutic leads in the pharmaceutical pipeline over the 
past few decades, resulting in increased demand for newer sustainable methods for drug 
discovery.  
Despite significant success in synthetic drug development efforts, natural systems are 
still a rich source for potent small molecule therapeutics. Although polyketides are an attractive 
target for drug discovery, their structural complexity impedes their synthetic preparation. The 
total synthesis of such natural products is extremely difficult, laborious and suffers from poor 
yields. Synthetic modification of existing scaffolds has some promise but can be extremely labor 
intensive and is limited in the range of transformations that can be selectively performed on 
these complex natural products.  
PKSs produce compounds with high medicinal activity and their structural and functional 
modularity has raised the possibility that polyketide biosynthesis pathways could be rationally 
reprogrammed by combinatorial manipulation to generate novel compounds of therapeutic 
significance.
7-13
 Many aspects of polyketide engineering can be manipulated to achieve 
diversification.  Product chain length variation can be achieved by varying the total number of 
modules in the PKS. Novel functionalities can be incorporated by introducing a variety of new 
primer and extender units, subject to the condition that substrate selection is controlled by AT 
enzymes. The oxidation state of the β-carbon as well as the stereochemistry can be modified by 
manipulating the DH, KR and ER of a module. Success in this direction is highly dependent on the 
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basic mechanistic understanding of the manner in which these molecules are biosynthesized 
13
 
and significant efforts have been made to use PKSs as platforms to generate newer and diverse 
drugs and therapeutics. 
 
Particularly in modular PKSs, there exists a distinct linearity in the protein structural 
organization and their function. This makes them a powerful model for efforts towards design 
and engineering of polyketide biosynthesis. Extensive work has been done with the aim of 
mixing and matching modules and domains from heterologous PKS proteins. Another approach 
is to use domain deletion, addition and domain swapping to generate novel, ‘’unnatural’’ 
polyketides. Numerous studies have been aimed to better our understanding of natural systems 
and in turn, improve our ability to manipulate them 
14-17
. However, these efforts have only 
Figure 1. Examples of commercial pharmaceutical drugs 
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achieved moderate success and are often faced with the issue of decreased productivity which 
could be due to structural instability of the engineered protein, sub-optimal chemistry within 
the altered module or problems with inter-modular transfer of polyketide intermediates in the 
assembly line 
14-17
. Another major hurdle is the intrinsic specificities within key enzymes 
responsible for production of polyketides which arises from lack of understanding their natural 
preferences.   Therefore there is an urgent need to explore more reliable means of investigating 
the molecular basis for key aspects of substrate selectivity of enzymes, intermodular 
communication and intermodular chain transfer.  
The research described in this thesis is aimed towards developing a set of highly desired 
molecular tools to facilitate the study of polyketide biosynthesis and ultimately improve 
polyketide engineering. 
1.2. Modular Polyketide Construction 
Modular PKSs are assemblies of covalently connected catalytic domains in the form of a 
large polypeptide. Each domain catalyzes a single chemical transformation and are collectively 
organized into modules. Each module, composed of its set of domains, brings about one round 
Figure 2. Proposed mechanism for polyketide formation in modular PKS 
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of chain elongation to the polyketide backbone (Figure.2). The variety in the organization of 
these large protein assembly lines gives rise to polyketides of great structural diversity.  
Chain growth is initiated by a loading module, followed by a number of extender 
modules that make up the body of the polyketide chain and the process is terminated by a 
release module. The first module contains a loading domain often composed of a loading acyl 
transferase (AT) domain and a loading acyl carrier protein (ACP) which loads the first extender 
module with an acyl substrate. Each extender module must contain at the least, an AT, ACP and 
ketosynthase (KS) domain to function. In addition to this, they may also contain combination of 
β-carbon processing enzymes such as a ketoredcutase (KR) domain, a dehydratase DH) domain, 
and an enoylreductase (ER) domain. The composition of these domains varies widely across 
different PKSs. The final module in this sequence generally contains a C-terminal thioesterase 
(TE) domain which releases the final polyketide product from the PKS 
4-7
. 
Polyketide synthesis proceeds in a manner that resembles an assembly line with 
individual components performing distinct tasks in a stepwise fashion to a specific product 
repeatedly. A starting unit in the form of a Coenzyme A derivative such as Propionyl-CoA is 
loaded onto the terminal thiol of the phosphopantetheinyl arm of the ACP of loading domain by 
the AT of the loading domain to form a thioester-bound acyl fragment. Chain extension begins 
with passing of the acyl fragment from the ACP to the cysteine active site of the first extender 
module KS (Figure 2). The AT loads the ACP of this module with an appropriate malonate-
derived extender unit. The AT strictly controls the choice of extender unit for a particular 
module and hence acts as gate keeper. The KS of this extender module catalyzes a 
decarboxylative Claisen condensation between its acyl unit and the extender unit on ACP 
forming an ACP-bound β-ketothioester product. The β-keto residue may then undergo 
sequential processing by KR to from an alcohol, DH to form an alkene and ER to form a 
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saturated chain.  Depending on the module, a given elongation step may stop at any of these 
intermediate products (keto, hydroxyl, enoyl) or result in the fully reduced β-carbon product. 
Upon completion of these steps, the chain is passed from ACP of this module to KS of next 
downstream module and the sequence of growth and processing repeats until the desired 
polyketide product is formed. Once the product is completed, the chain is passed to the TE 
where it catalyzes release of the product either by hydrolysis or cyclization. The choices of 
building blocks made by each module and the number and types of domains within each module 
catalyzing postcondensation reactions dictate the chemical functionality at each carbon atom in 
the final product. 
1.2.1. 6-derythronolide B synthase (6-DEBS) 
The most well studied modular PKS is 6-deoxyrythronolide B synthase (DEBS) which is 
responsible for assembly of 6-deoxyerithronolide B (6-DEB), the macrolide precursor to 
Figure 3. 6-deoxyerythronolide B synthase (DEBS)  
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erythromycin A. 6-DEBS has become the archetype of modular PKSs. The entire DEBS has been 
successfully expressed in the heterologous hosts such as Escherichia coli. Recombinant strains of 
E.coli have been engineered specifically to optimize the expression of the DEBS proteins
4-6
. The 
ability to efficiently express PKS proteins in engineered heterologous hosts has provided a 
greatly simplified platform to perform PKS investigations.   
DEBS consists of six modules grouped into 3 large polypeptides DEBS1, DEBS2 and 
DEBS3 (Figure 3.) where each contains two modules. The loading didomain consisting of ACPL 
and ATL, loads propionyl-CoA onto the KS of the first extender module.  The AT of the first 
module loads the ACP of that module with methylmalonyl-CoA as an extender unit.  Similarly, all 
other ATs in DEBS incorporate a methylmalonyl-CoA unit onto their respective ACP.  All six 
modules harbor a KR, while KR of module 3 is inactive. Module 4 carries a DH domain and ER 
domain as well as a TE at the C-terminus for releasing the final macrocycle.  As in all PKSs, the 
precise composition and specificity of these domains provide the diverse stereochemistry and 
oxygenation patterns in the final macromolecule. Much of what is known about the molecular 
mechanisms of modular PKSs is derived from extensive investigations of the DEBS. These large 
PKS modules were not very suitable for performing in-depth investigation of mechanistic steps 
of each individual domain. A substantial advancement in this area came from limited proteolysis 
studies that revealed highly conserved interdomain boundaries at which individual modules 
could be further disconnected to form fully functional PKS subunits. Upon proteolytic cleavage, 
functional domains are released and their exact domain boundaries are calculated by N-terminal 
sequencing analysis 
12,13
. This gives rise to domains such as KS-AT, ACP, TE, AT-ACP loading 
didomain and other beta carbon processing sub-units as stand-alone entities. For instance, by 
identifying cleavage sights located in the amino acid sequence, it was possible to express a 
homodimeric [KS][AT] didomain possessing full catalytic activity that could be used for stepwise 
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structural and functional analysis 
13
. This approach has been used extensively to perform in-
depth analysis of DEBS enzymes and their functions which in turn have helped understand the 
working modular PKSs. 
1.3. Traditional Methods for PKS investigations 
In the past, a number of approaches have been utilized to investigate various aspects of 
the PKS biosynthetic machinery. Some key approaches have been described in the following 
sections. Despite having their uses in some areas of application, they suffer from certain 
shortcomings in other areas which reinforce the need for newer tools for investigation of PKSs. 
1.3.1. Radiolabeling  
For many decades now, radiolabeling has been extensively used for in vivo as well as in 
vitro PKS biosynthesis investigations. DEBS is the most well studied PKS using these techniques.  
Traditionally, it was used for incorporation in vivo of radiolabelled substrates to probe the 
mechanism of biosynthesis by analyzing of the final product
18a, b
. The radiolabelled substrates, 
[2-
2
H2, 2-
13
C] propionate and [2-
2
H2, 2-
13
C] methylmalonyl-CoA were fed to the bacterial cultures 
of S. Erythrea, and the polyketide product were isolated and analyzed by scintillation count and 
using 
13
C NMR. The incorporation of the radiolabels into the erythromycin macrolide gave 
insight about the mechanism of condensation and chain extension.  The observation of specific 
stereochemistry such as generation of D-methyl groups in the carbon skeleton of the final 
molecule provided strong evidence for analogy to fatty acid biosynthesis. However the scope of 
this approach limited due to poor yields in vivo, inability to isolate crucial intermediates and 
failure to address key aspects such as protein-protein and protein-substrate interactions, 
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substrate recognition of individual domains and precise mechanism of individual steps in chain 
transfer and elongation.  
1.3.1.1 Radiolabeling with 6-DEBS 
A more direct way of gaining insight into these key questions involved carrying out 
experiments with PKS proteins in vitro which made it possible to probe the PKS multienzymes 
under controlled conditions such as temperature, buffer, and in the absence of metabolic 
constraints. The use of heterologous hosts such E. Coli to express these proteins in good yields 
has greatly facilitated this approach. Additionally, in vitro environments provide a cleaner 
background for the isolation of polyketide products.  To facilitate this approach, the DEBS was 
shortened into smaller model systems by moving the thioesterase (TE) domain from DEBS3 to 
the end of DEBS1 and DEBS2 to form DEBS1+TE and DEBS2+TE resulting in premature release of 
the chain at the triketide stage 
20
. This revolutionary approach introduced an efficient 
alternative to working with these enormous intact protein systems. The truncated modules 
were incubated with radiolabelled coenzyme A derivatives to obtain chain extension and release 
of the cyclized products which were analyzed by thin layer chromatography with 
autoradiography or phosphorimaging. For example, incubation of module 2+TE with appropriate 
analogue of the natural diketide-SACP substrate of KS of DEBS module 2 and MeMal-CoA for the 
ACP gives an acyclic triketide that is released from the enzyme by TE catalyzed cyclization to 
yield triketide lactone (Figure 4.). The radiolabeled product were extracted out of the samples 
and analyzed by liquid scintillation counting which quantifies the amount of radiolabeled 
product formed. The amount of radiolabeled product provides measure of enzyme loading and 
substrate turnover.  
10 
 
The use of isolated PKS enzymes has made it possible to perform extensive biochemical 
analysis of substrate specificity, kinetics, and stereochemical preferences 
14-17, 20
. However, an 
intrinsic limitation of in vitro studies is the greatly reduced (~1µg) quantities of polyketide 
products that are ordinarily generated in such experiments, which require the independent 
preparation of authentic reference samples by laborious total synthesis. Additionally, the high 
cost of required coenzyme A thioesters needed for chain extension prohibits larger scale in vitro 
synthesis of polyketides.  
As described previously, limited proteolysis studies yielded all the individual domains 
from DEBS. Isotopically labeled SNAc thioesters are extensively used along the same lines as 
described above with these stand-alone protein units by loading the ACP and KS domains and 
performing chain elongation 
21
. By far, the most significant advantage of this method is the 
ability to carry out multiple turnover experiments with discrete ACP and KS-AT domains in the 
absence of TE which was previously necessary to release covalently bound products from the 
enzyme. 
1.3.1.2.  N-acetylcysteamine thioesters 
The discovery of simple synthetic mimics of coenzyme A substrates in the form of N-
acetylcysteamine(SNAC) thioesters brought about a great advancement in this field. These SNAC 
thioesters were more economical, easily prepared and demonstrated to be good substrates of 
PKS enzymes 
22
. The N-acetylcysteamine (NAC) is a truncation of the coenzyme A side chain and 
  
Figure 4. Conversion of Diketide-SNAc to Triketide lactone  
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hence acts as the recognition motif for PKS enzymes. In the first report, the methylmalonyl-SNAc 
was incubated with DEBS3 along with a [
13
C] labeled diketide primer to test product formation. 
The organic extract of the reaction was analyzed by 
13
C NMR and confirmed the formation of the 
expected triketide lactone. This experiment confirmed the acceptance of these SNAc thioesters 
as good substrates for PKS enzymes, following which, a large number of other SNAc thioesters 
have been prepared and widely used as coenzyme A substitutes.  
As an example of radiolabeling experiments of DEBS hybrid modules with use of SNAc 
thioesters and their analysis, Figure.5 outlines an assay performed with hybrid module 
containing ACP3, KS5 and TE of DEBS (M3M5TE). The module is incubated with substrates for 
ACP and KS and the labeled proteins are visualized by radio-SDS-PAGE whereas the small 
molecule output of triketide lactone is visualized by radio-TLC.  
In all, radiolabelling techniques have been vastly used to probe the activities and 
behavior of various PKS enzymes. The major drawback of this approach is the prohibitively 
expensive reagents that limits the availability of diverse substrates and restricts applications to 
Figure 5. Analysis of radiolabeling experiments 
(A): Radio SDS−PAGE of [
14
C] 2-methyl-3-hydroxylpentynoyl-SNAc labeling of M3M5TE hybrid 
module and ACP2. (B): Radio SDS−PAGE of [
14
C]Methylmalonyl-CoA labeling of M3M5TE and ACP5 
and (C): Radio TLC Triketide lactone formation by DEBS hybrid module. 
21
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smaller scales. Here lies the gap in biotechnology to develop simpler strategies to investigate 
PKS enzymes and biosynthesis which can overcome the handicaps discussed above.    
1.3.2. Mass spectrometry 
More recently, mass spectrometry has emerged as a powerful tool for biological analysis 
as a result of its sensitivity, accuracy and speed and has been used for structure elucidation of 
polyketides and observing aspects of PKS biosynthesis 
29-34 
During the biosynthesis of 
polyketides, substrates, intermediates and side products are covalently tethered to the PKS, 
introducing mass changes, making these biosynthetic systems ideal candidates for interrogation 
by large molecule mass spectrometry.  MS can be used to understand substrate tolerance, 
timing of covalent linkages, timing of tailoring reactions and the transfer of substrates and 
biosynthetic intermediates from domain to domain. 
Controlled limited proteolysis has been used to release and separate entire functional 
domains from modular PKSs such as DEBS which enables to probe the function and organization 
of the domains within the intact modules 
12,13
. For instance, DEBS hybrid units such as DEBS1-TE, 
DEBS3 and the DKS(loading didomain+module1, called diketide synthase) were subjected to this 
method 
31
. The intact muti-domain units were digested with trypsin and monitored by LC-MS to 
separate the fragments and analyze them using sequence alignments and N-terminus 
sequencing to identify the separated domains. For instance, the DEBS1(loading 
didomain+module1+module2) proteolysis gave rise to many single and multidomains such as 
KS1, AT1, TE, KR1, ACP2-TE, ATL-ACPL(AT and ACP of loading domain).  Similarly, the proteolysis 
of the DKS unit gave another array of domains. The ability to isolate these individual domain and 
domain pairs enabled the study of acylation specificities for each individual AT, ACP and KS. For 
13 
 
instance, Propionyl-CoA, the native substrate for the DEBS loading module, was incubated with 
intact DKS followed by proteolysis to release the domains for analysis. By analysis of mass peaks, 
it was revealed that propionyl units were specifically loaded onto ATL-ACPL and KS1 but not on 
AT1, KR1, ACP1 or TE domains. This indicated that propionyl-CoA is not a suitable substrate for 
the extender AT1 and ACP1 domain. Experiments with the non-natural substrate n-butyryl-CoA 
with DEBS1 and DKS showed similar results also indicating sufficient mass accuracy to 
distinguish between propionyl and butyryl groups. In this manner, numerous substrates studies 
have been conducted with these domains by observing the stable acyl intermediates.  
Along similar lines, individual domains such as ACP, TE and [KS][AT] didomians were 
engineered and expressed in E.Coli 
13
. A method was developed to achieve complete proteolysis 
of didomain to enable the direct detection of covalently bound substrates by MS. For example, 
in an experiment, the substrate specificity of KS from DEBS module 3 was examined by pairwise 
combinations of various di- and tri-ketide-SNAc thioesters and observation of KS acylation. The 
specificity for each substrate was measured by the relative proportions of each acyl-enzyme 
species, as determined by LC-MS (Figure 6.). Also, by doing time points of incubation, relative 
rates of acylation and step-wise kinetic analysis can be performed. KS-catalyzed chain 
elongation in the presence of the methylmalonyl-ACP was performed with these different KS 
substrates. The use of discrete ACP and [KS][AT] domains allowed multiple turnover 
experiments by use of excess ACP. Direct proteolysis of the mixture followed by LC-MS analysis 
provided peptide fragment peaks corresponding to the KS and ACP domains at various stages of 
polyketide extension. Kinetic analysis provides detail insight into comparative rates of ACP 
loading, KS acylation by diketide substrate and chain elongation event. One major advantage of 
this method over traditional radiolabeling is that both acylation and elongation can be 
 monitored simultaneously. It has
examinations. 
 
Figure 6. [KS][AT] didomain 
In this manner, mass spectrometry has grown into powerful yet sensitive and reliable 
method to assay ACP and KS acylation events. It has been used in limitless application including 
study of substrate specificities of PKS enzymes, examination of various heterologous ACP
pairs, kinetic evaluation of chain elongation steps and PKS protein chemistry
 Despite many improvements over traditional techniques, mass spectrometry has some 
shortcomings. Firstly, the full PKS modules that are about 300 kDa in size cannot be used in this 
assay due to which smaller subunits are used as substitutes such as the [
remains unclear whether such a substitution has any effect on actual PKS enzyme specificities. 
Secondly, there is the question of effect of substrates on ionization potentials when proteolysis 
is performed. This could adversely affect 
14 
 also eliminated the need to use expensive radiolabels for PKS 
 
acylation observed by LC-MS 
. 
KS][AT] didomain. It 
data interpretation and its reproducibility. Lastly and 
-KS 
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most importantly, substrates with high hydrophobicity are susceptible to solubility issues which 
affect the signal in MS which limits the chemical diversity of substrates. 
1.4. Hypothesis 
As summarized in this chapter, mass spectrometry and radiolabeling strategies 
combined with genetic engineering and molecular biology tools, have been successful for many 
aspects of PKS investigations. The high reagent cost, limited substrate availability in case of 
radiolabeling, and inability to perform direct PKS investigations using MS methods restrict their 
use in medium to high-throughput applications essential for investigating the rapidly emerging 
new PKS systems. There exist many reliable methods to study KS substrate specificities by 
directly loading the KS active-site which have been discussed above. This has enabled enormous 
KS-centered analysis of chain elongation kinetics, inter-domain and inter-modular chain transfer 
but little is known about other aspects, for example, the tolerance of KS towards diverse non-
natural extender units. 
 Nearly all biosynthetic steps associated with modular PKS systems rely on acyl-ACPs. 
Therefore, functional analysis of each enzymatic event would require a robust method of 
Figure 7. holo-Acyl Carrier protein with Ppant arm 
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generating and monitoring their fate. Despite the central and highly functional role played by 
ACPs in polyketide biosynthetic processes, ACP-based PKS examination strategies are highly 
underdeveloped mainly due to insufficient techniques to perform ACP modifications. The strict 
AT specificities limit the variety of natural substrates for ACP and have prevented efforts of AT-
mediated modification of ACP using synthetic substrates. Traditionally, ACPs are modified by 
small molecules via acylation of coenzyme A and subsequent PPant transferase-catalyzed 
transfer to the apo form of ACP. Synthesis of these CoA analogues is labor intensive, costly, and 
scale-up is tricky
23-26
.  Another method utilizes the CoA pathway to introduce thioether-linked 
substrates onto the ACP via generation of synthetic CoA analogues 
27-29
. While a very powerful 
approach, this technique requires extensive genetic manipulation and resulting thioesters 
cannot be processed by PKS enzymes that recognize thioester linked species and therefore are 
of limited use to PKS investigations. As genomic-based technologies continue to supply an 
abundance of new PKS systems, there is an urgent need for complimentary methods using 
simple, reliable and structurally flexible ACP-acylating agents. 
We were convinced that ACPs, with their ability to interact with many proteins and carry 
out a range of vital functions, were the ideal choice for introducing chemical substrates, labels, 
and intermediates onto PKSs (Figure 7, 8). To achieve this, there is a need to develop a method 
Figure 8. Acyl Carrier Protein enzyme partners 
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to introduce novel substrates with wide structural diversity onto the ACP and generate 
functional donor-ACPs to utilize them in PKS investigations. We reasoned that a suitable strategy 
would be to design appropriately reactive small molecule functionalities and target them 
towards a biomacromolecular site within the PKS. The terminal thiol PPant of ACP is a unique 
nucleophile in PKSs and being positioned on a long flexible prosthetic arm imparts it great 
accessibility and distinctive reactivity to ACPs in the presence of a multitude of other 
nucleophiles such as cysteine, serine, lysine and tyrosine.  
As outlined in the rest this document, our aim is to target the PPant arm of the acyl 
carrier protein. The hypothesis is that, with the right electrophilic partner for this terminal thiol 
using small molecules, we can achieve site-specific labeling and generate acyl-ACPs to gain a 
direct access into the PKS machinery. 
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CHAPTER 2 
 DIRECT ACYLATION OF CARRIER PROTEINS WITH β-LACTONES 
2.1 Introduction 
Acyl carrier proteins are critical components of fatty acid and polyketide biosynthesis . 
Their primary function is to shuttle intermediates between active sites via a covalently bound 
phosphopantetheine arm. Majority of biosynthetic steps involved in modular PKS systems rely 
on acyl-ACPs 
3
. Therefore, a reliable method for generating acyl-ACPs and monitoring their fate, 
will greatly aid step-wise functional analysis of PKSs. Our hypothesis was that the Ppant group 
may be uniquely reactive, given an appropriate electrophilic partner, and therefore, targetable 
for direct acylation. We reasoned that small molecules capable of acylating this prosthetic group 
will provide a simple and reversible means of introducing novel functionality onto carrier protein 
domains. We were interested in using β-lactones for directly labeling acyl carrier proteins (ACPs) 
via the phosphopantetheine(Ppant). This strategy was particularly appealing since, β-
Hydroxythioesters, formed by addition of the PPant thiol to a β-lactone, are common 
components of polyketide intermediates. 
There is substantial precedence of electrophilic groups used as partners for nucleophiles 
in biological systems. Many biologically active natural products have electrophilic functional 
group cores that target nucleophilic residues as a part of their mechanism of action. Some well 
documented examples of such a feature are lipstatin, penicillin, cerulenin, orlistat 
1,2
. They are 
perfect examples of how electrophilic groups such as the carbonyl group, the epoxide and the 
electron deficient alkene are protein-reactive chemical entities. These electrophiles covalently 
modify their nucleophilc targets to inhibit or deactivate them.  The lipstatin family of natural 
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products features a four-membered β-lactone ring. The chemical reactivity of this ring is the 
basis of their biological activity. The catalytic active-site serine nucleophile of their target 
enzyme attacks the electrophilic carbonyl of the β-lactone to form a β-hydroxy serine ester. In 
case of lipstatin, it has been experimentally confirmed that the reaction is exclusively at the 
carbonyl site giving an ester and not an ether product
3
.  
2.1 Results and discussion 
We began by preparing an alkyne-bearing β-lactone, compound 1 (Figure 9.)
5
, for 
performing the ACP-acylation approach. The ACPs used for this study were from modules 2 
(ACP2) and 3 (ACP3) of the 6-deoxyerythronolide B synthase (DEBS) that were isolated, 
overexpressed and purified in both apo and holo forms, using BL21 and BAP1 cells, respectively. 
To test selective Ppant acylation, the reagents were incubated with these isolated holo- and 
apo-ACP domains. The criteria for a successful reagent were to exhibit selectivity for the holo 
structures, without nonspecific acylation of the apo ones. Competition from nucleophiles 
present on other common PKS domains was a primary aspect to be observed carefully. We were 
aware that, to be truly useful, our probes must avoid reaction with them. Prior studies report KS 
Figure 9. β-lactone for ACP-acylation 
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active site to be competent nucleophiles for β-lactone ring-opening 
6
, as a result,  KS-AT 
didomain from DEBS module 6 (KS-AT6) was overexpressed and purified 
7-8
. 
 There is precedence in this matter, where minimal reactivity between compound 1 and 
the KS domain of bacterial fatty acid synthase was observed 
6
. We were interested in testing the 
purified DEBS KS domain in this respect to see how it behaved in these conditions. In this 
manner, the stage was set to examine  both efficiency and selectivity of ACP-acylation with β-
lactones. 
As discussed earlier, tandem proteolysis-mass spectrometry has emerged as a powerful 
means of detecting PKS-bound small molecules in vitro 
9-11
. By extensive trypsinolysis of apo- 
and holo-ACPs, a series of peptide fragments were produced, including one containing the 
conserved DSL motif, to which the Ppant is attached in samples derived from BAP1 as 
determined by LC-MS. Incubation of holo-ACP2 and -3 with varied equivalents of 1 at pH 7 for 1 
h followed by exhaustive trypsinolysis and LC-MS, to determine the fraction acylated, produced 
saturation curves which indicated that a roughly 50-fold excess of lactone is required for 
Figure 10. Saturation curves of alkyne β-lactone  
ACP3 (yellow), ACP2 (blue), and KS-AT6 (red) treated with compound 1, trypsinized and 
analyzed by tandem proteolysis-mass spectrometry. Equivalents of lactone are per protein 
molecule. Each data point is the average of three experiments. Standard deviations are shown 
as black error bars. Lines are added for clarity. 
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complete acylation (Figure 10.). The results were that both apo-ACPs showed no acylation with 
50 equiv of lactone, providing further evidence that the reaction is occurring on the Ppant arm 
as this is the only difference between the apo and holo forms of ACP. In comparison, the 
saturation curve for KS-AT6 showed 25−50% less acylation than ACP for the range of lactone 
equivalents tested. Most importantly, at 10 lactone equivalents, the ACPs were approximately 
35−50% loaded while the KS was mostly unreactive after 1 h of incubation. Standard deviations 
for these experiments were generally within 1−4% suggesting that the differential reactivity 
observed was genuine. 
 By means of tandem proteolysis/LC-MS it was confirmed that the acylation occurs at 
the PPant group. However, not all proteolysis products readily ionize under the conditions used. 
In addition, we could not rule out the potential for acylation of the peptide fragments over the 
intact protein. As an alternative, a gel-based assay was designed according to previous work by 
Sieber and co-workers 
6
. Each ACP (apo and holo) and KS-AT6 was incubated for 1 h with 10 e 
SDS-PAGE analysis of the resulting mixtures showed bright fluorescent bands corresponding to 
holo-ACP2 and -3 while the apo-ACPs and KS-AT6 displayed only background fluorescence 
(Figure.11.). These results provide initial indication that β-lactones can be selective for ACP over 
KS as well as avoid other potential competing residues such as surface cysteines, serines, and 
lysines.quiv of 1 followed by 1,3-dipolar cycloaddition (“click”) reaction with rhodamine azide 
12-
14
.  
At this point, the functionality of the acyl-ACP intermediates needed to be established 
along with the evidence of thioester over thioether formation. Preloaded ACP2 and ACP3 (10× 
compound 1) were mixed with KS-AT6. After 1 h, the click reaction was performed as before and 
the proteins separated by gel electrophoresis.  
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Bright bands corresponding to the KS-AT6 didomain indicate that the β-
hydroxythioester is efficiently transferred from the ACPs (Figure 11). It should be noted that 
direct KS-acylation is not observed under the conditions used in these experiments.  
The next step was to examine β-lactone behavior with a higher level of biological 
complexity for which we overexpressed and purified apo and holo forms of the intact module 2 
from spinosyn synthase (SpnB). This particular module was chosen because it contains KS, AT, 
DH, ER, KR, and ACP domains which represent the vast majority of synthase components 
present in a given assembly. Both apo and holo forms of spinosyn module 2 were incubated for 
1 h with 10, 50, and 75 equiv of 1 followed by “click” reaction with rhodamine azide and PAGE 
analysis as before (Figure 12.). Again, the only difference between apo and holo forms was the 
Reaction with compound 1 and subsequent click reaction with rhodamine-azide. Lanes are 
marked above with the corresponding protein component. Markers to the left indicate 
expected bands for the indicated species. The right two lanes depict transfer of the 
acylation product from preloaded ACP to KSAT indicating that the intermediates are 
functional. β-Lactone was applied at 10× relative to protein unless otherwise noted. ACP2 
contains a C-terminal linker region accounting for its larger mass. 
Figure 11. PAGE analysis of fluorescently labeled DEBS ACP3, ACP2, KS-AT3, and KS-AT6 
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 absence or presence of the Ppant group, respectively. To our satisfaction, only the holo-protein 
showed significant fluorescence indicating that Ppant-thiol is the only competent partner for 
acylation among a multitude of alternative nucleophiles.Encouraged by these analyses with the 
alkyne-β-lactone, we began examination of a diverse panel of β-lactone structures. Compounds 
2−5 were added to holo-ACP2 and -3 as well as KS-AT6 at 10- and 50-fold excess and allowed 1h 
of incubation, followed by proteolysis and LC-MS analyses. Acylation efficiencies, calculated as 
percent loading, were obtained from peak heights of acylated peptides divided by the total 
peptide (acylated plus unreacted) peak heights for a given LC-MS run (Table 1). 
 
 
Figure 12. SDS-PAGE analysis of fluorescently labeled SpnB  
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Table 1. Loading of ACP2, ACP3, and KS-AT6 with β-lactone 
  
loading, % 
compd equiv of lactone ACP2 ACP3 KSAT6 
1 10 33 55 7 
 
50 93 97 64 
2 10 78 64 26 
 
50 97 97 65 
3 10 53 62 41 
 
50 96 94 62 
4 10 8 13 6 
 
50 32 36 14 
5 10 7 15 27 
 50 28 35 58 
 The series of β-lactones tested with the ACP and KS showed different levels of acylation 
but an interesting trend emerges from this study. The monosubstituted, alkyl-lactones, 
compounds 1−3, are quite reactive toward both ACPs tested. In contrast, the disubstituted 
lactone, compound 5, shows little ACP-acylation activity even at 50 equiv. KS-AT6, on the other 
hand, is more reactive than ACP2 and -3 toward compound 5 but significantly less reactive with 
compounds 1−3 than the ACPs. Finally, the monosubstitued, aromatic lactone, compound 4, 
reacts sluggishly with both ACP and KS. These data offer promising preliminary evidence that β-
lactones can provide an efficient and selective means of acylating carrier proteins. High excess 
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of lactones required for ACP-saturation was a primary concern. We wanted to address this issue 
to improve the performance but given the limited scope of refining the structure of β-lactones 
to improve reactivity, we looked towards other suitable electrophilic partners for ACP thiols. 
2.2 Experimenatal details 
5-hexynal : 20 mL of anhydrous dichloromethane (DCM) were cooled in a dry-ice/acetone bath 
and oxalyl chloride (13.0 mmol) was added by syringe and stirred for several minutes. DMSO 
(13.0 mmol) with10% v/v DCM was added dropwise by syringe. After gas evolution ceased, the 
mixture was stirred for five minutes then 5-hexyn-1-ol (5.20 mmol) was added by syringe and 
stirred for five minutes. 
Triethylamine (26.01 mmol) was added by syringe and the mixture stirred for 15 minutes and 
warmed to RT. The product was washed with 0.5 M HCl and ½ saturated NaHCO3, and dried over 
MgSO4. The product was purified by flash chromatography over silica gel using 9:1 
Hexanes:EtOAc mobile phase. 5-hexynal: 0.4200 g, 4.37 mmol of product, 84%, colorless oil. 
1
H NMR (400 MHz, CDCl3) δ: 9.811 (s, 1H), 2.619 (t, J = 7.05 Hz, 2H), 2.278 (dt, J = 6.70 Hz, 2.45 
Hz,2H), 1.999 (t, J = 2.38 Hz, 1H), 1.858 (quint J = 7.00 Hz, 2H) 
13
C NMR (100 MHz, CDCl3) δ: 201.719, 83.188, 69.386, 42.530, 20.809, 17.772 
General procedure 1: aluminum-catalyzed generation of β-lactones from aldehydes and acid 
chlorides
15
. 
A suspension of anhydrous AlCl3 (0.1 eq) and AgSbF6 (0.3 eq) in DCM cooled to -60°C in an 
ethanol/ethylene glycol/dry ice bath, was added by syringe: N,N’-diisopropylethylamine (DIEA) 
(1.5 eq), acid chloride (1.5 eq) and aldehyde (1 eq). The mixture was stirred for five hours at -
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60°C then filtered through a silica plug. Then product was purified by flash chromatography over 
silica gel with a hexanes:ethyl acetate mobile phase. 
General procedure 2: Nucleophile-catalyzed production of β-lactones from aldehydes and acid 
Chlorides 
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For some reactions DABCO was substituted for the quinine catalyst, owing to the similar nature 
of the nucleophillic substituent. 
To a solution of trimethylsilyl quinine (TMSq3) (0.1 eq) or (DABCO) (0.2 eq) and LiClO4 (1.0 eq) in 
30 mL of DCM and 10 mL of Et2O cooled to -78°C in a dry ice-acetone bath, was added via 
syringe DIEA (3.0 eq), and aldehyde (1 eq). Acid chloride (1 - 2 eq diluted in DCM) was added 
dropwise over ca. 3 hours. The mixture was stirred for 8 hrs at -78°C then diluted with an equal 
volume of ether and allowed to come to room temperature. The mixture was filtered through a 
silica plug then purified by flash chromatography over silica gel with a hexanes:ethyl acetate 
mobile phase. 
4-(pent-4-yn-1-yl)oxetan-2-one (1): General Procedure 1: AlCl3 (0.0427 mmol), AgSbF6 (0.1281 
mmol), acetyl chloride (0.5976 mmol), DIEA (0.6656 mmol), 5-hexynal (0.4300 mmol). 3: 0.2389 
mmol (56%), pale yellow oil. 
1
H NMR (400 MHz, CDCl3) δ: 4.567 – 4.539 (m, 1H), 3.529 (dd, J = 16.76 Hz, 1.76 Hz, 1H), 3.129 
(dd, J = 16.29 Hz, 1.67, Hz, 1H), 2.286 (dt, J = 6.61 Hz, 1.46 Hz, 2H), 2.001 (t, J = 2.4, 1H), 1.720 – 
1.644 (m, 4H). 
13
C NMR (100 MHz, CDCl3) δ: 168.101, 83.236, 70.785, 69.355, 43.029, 33.590, 23.867, 17.982. 
Hi-res FAB MS calculated m/z for C8H11O2 [M+H]+ = 139.075356. Observed m/z = 139.0766. 
4-propyloxetan-2-one (3): General Procedure 1: AlCl3 (0.99 mmol), AgSbF6 (2.9 mmol), acetyl 
chloride (11 mmol), DIEA (11), butanal (9.8 mmol). 2: 8.134 mmol (83%), colorless oil.  
1
H NMR (400 MHz, CDCl3) δ: 4.530 (dt, J = 2.96 Hz, 5.76 Hz, 1H), 3.522 (dd, J = 16.31 Hz, 5.78 Hz, 
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1H), 3.067 (dd, J = 16.29 Hz, 4.28 Hz), 1.1.871 – 1.838 (m, 1H), 1.833 – 1.745 (m, 1H), 1.56 – 1.36 
(m, 1H), 0.986 (t, J = 7.40 Hz) 
13
C NMR (100 MHz, CDCl3) δ: 166.477, 69.238, 41.036, 34.826, 16.429, 11.802 
4-(4-nitrophenyl)oxetan-2-one (4): General Procedure 2: DABCO (0.6 mmol), DIEA (9 mmol), 
LiClO4 (3 mmol), p-nitrobenzaldehyde (3.0 mmol), acetyl chloride (3.0 mmol). N: 1.35 mmol 
(45%), pale yellow oil. 
1
H NMR (400 MHz, CDCl3) δ: 8.30 (d, J = 8.88, 2H), 7.60 (d, J = 8.46 Hz, 2H), 5.63 (dd, J = 6.3 Hz, J 
=4.5 Hz, 1H), 4.04 (dd, J = 16.4, J= 6.3, 1H), 3.44 (dd, J = 16.5, J = 4.5, 1H) 
13
C NMR (100 MHz, CDCl3) δ: 166.51, 148.42, 144.40, 126.50, 124.36, 69.51, 46.90 
3-methyl-4-propyloxetan-2-one (5): General Procedure 2: TMSq (0.3 mmol), DIEA (7.5 mmol), 
LiClO4 (3.0 mmol), butyraldehyde (3.0 mmol), propionyl chloride (3.0 mmol). N: 1.68 mmol 
(56%), colorless oil. 
1
H NMR (400 MHz, CDCl3) δ: 4.60 – 4.55 (m, 1H), 3.79 – 3.17 (m, 1H), 1.80 – 1.69 (m, 1H), 1.68 – 
1.61 (m, 1H), 1.59 – 1.49 (m, 1H), 1.47 – 1.38 (m, 1H), 1.28 (d, J = 7.8 Hz, 1H), 1.00 (t, J = 7.4 Hz, 
1H) 
13
C NMR (100 MHz, CDCl3) δ: 172.86, 75.56, 47.22, 32.00, 18.79, 13.79, 8.06 
Sulforhodamine-B Azide (SrB-A): 3-azido-1-aminopropane
18
 (0.22 mmol) and triethylamine (0.5 
mmol) was dissolved in 1 mL of 5:1DCM:DMF and cooled to 0°C in an ice-water bath. 
Sulforhodamine B sulfonyl chloride [mixture of ortho- and para- sulfonyl chloride isomers] (0.20 
mmol) was added portion-wise over ca 30 min and stirred overnight at room temperature. The 
product was purified by flash chromatography over silica gel with 90:5:5 DCM : acetonitrile : 
methanol mobile phase. The ortho isomer was distinguished by its reversible color change in in 
pH 9.0 buffer
19
. Para isomer (SrB-pA): 17%, ortho isomer (SrB-oA) 14%. Srb-oA was found to 
perform best in the click reaction and was utilized for labeling experiments. 
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NMR spectra are of poor quality due to long relaxation times. Product is pure by LC-MS. 
Hi-res FAB MS calculated m/z for C30H37N6O6S2 [M+H]+ = 641.221049. Observed m/z = 641.2216. 
3. Plasmid Construction 
pCAD01 was prepared from an E. coli optimized synthetic construct (DNA2.0, Menlo Park, CA). 
The synthetic gene was excised from the shipping vector via flanking NdeI and NotI restriction 
sites and ligated into pET21b. 
4. Protein Expression and Purification 
SpnB was expressed from pCAD01. KSAT3 and KSAT6 were expressed from pAYC02 and 
pAYC11
20
respectively. ACP2 was expressed from pNW6
21
, ACP3 was expressed from pVYA05
22
. 
Apo SpnB and ACPs were expressed in E. coli BL-21 cells and Holo SpnB and ACPs were 
expressed in E.Coli BAP-1
23
. pCAD01, pAYC02, and pAYC11 contain ampicillin resistance vectors, 
pNW6 and pVYA05 contain kanamycin resistance vectors. 
General Procedure for Protein Expression and Isolation 
Bacteria were grown in 1 L shake cultures of LB-antibiotic media at 37°C in a New Brunswick 
Scientific Excella E24 Incubator Shaker until the OD600 was between 0.6 and 0.8. 
Overexpression was induced with 200 μL of 1 M IPTG and carried out at 18°C for 18 hours, after 
this point all work was carried out at 4°C. Cells were pelleted by spinning at 3000 RPM for 10 
minutes in a Sorvall RC6 Plus with a FiberLite F21S-8x50 rotor and resuspended in 50 mL of lysis 
buffer (20 mM Tris-HCl, 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium 
pyrophosphate, 1 mM β-glycerophosphate, 1 mM sodium Na3VO4, 1 μg/mL leupeptin, pH 7.5). 
Cells were lysed using a Misonics ultrasonic converter without microtip, amplitude 30 for five 30 
second intervals with a 60 second cool down period between each. Lysed cells were spun at 
10,000 rpm and with a FiberLite F10S5 6x500 Y rotor for 60 minutes. The lysate was equilibrated 
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with 3 mL of PerfectPro Ni-NTA bead slurry for 60 minutes by stirring with a PTFE-coated stir bar 
at 60 RPM for 60 minutes. The lysate was then poured into a 15 mL column and the supernatant 
eluted. The column was then washed with two 15 mL portions of wash buffer (50 mM 
phosphate, 300 mM NaCl, 20 mM imidazole, pH 8.0), and eluted with 3 mL of elution buffer (50 
mM phosphate, 300 mM NaCl, 250 mM imidazole, pH 8.0). The purified protein was loaded into 
an Amicon Ultra centrifugal concentrator and diluted to 15 mL with storage buffer (100 mM Tris, 
1 mM EDTA, 1 mM dithioerythritol, 10% glycerol pH 8) and spun at 3000 rpm in Eppendorf 
Centrifuge 5810 R with swinging-bucket rotor. Dilution and filtration was repeated a total of 
three times. Protein concentration determined by Bradford assay, average concentration was 
approximately 500 μM. Proteins were flash frozen and stored at -80°C until use. 
5. Loading Proteins with β-lactones 
Labeling reactions for gel assays were performed at 20 μL total volume, reactions for LC-MS 
were performed at 50 μL total volume. Final concentrations reported in procedure. 
Loading ACPs 
Phosphate buffer (100 mM, pH 7), tris(2-carboxyethyl)phosphine (2.5 mM), and protein (0.025 
mM) were reacted at ambient temperature for 15 min. Then β-Lactone was added to the 
appropriate concentration (1, 5, 10, 20, 50, or 75x with respect to protein for saturation 
experiments, 10 or 50x with respect to protein for loading experiments) and the mixture reacted 
at ambient temperature for 60 min. 
Loading KSATs 
Phosphate buffer (100 mM, pH 7), tris(2-carboxyethyl)phosphine (2.5 mM), and KSAT (0.025 
mM) were reacted at ambient temperature for 15 min, then β-Lactone (2.5 mM) was added (1, 
5, 10, 20, 50, or 75x with respect to protein for saturation experiments, 10 or 50x with respect 
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to protein for loading experiments) and the mixture incubated at ambient temperature for 60 
min. 
Loading SpnB 
Phosphate buffer (100 mM, pH 7), tris(2-carboxyethyl)phosphine (2.5 mM), and SpnB (0.015 
mM) were reacted at ambient temperature for 15 min, then β-Lactone was added (10, 50, or 
75x with respect to protein) and the mixture incubated at ambient temperature for 60 min. 
Acyl Transfer 
Phosphate buffer (100 mM, pH 7), tris(2-carboxyethyl)phosphine (2.5 mM), and ACP (0.025 mM) 
were reacted at ambient temperature for 15 min. Then β-Lactone (10 equivalents) was added  
and the mixture reacted at ambient temperature for 60 min. Then KSAT was added and the 
mixture incubated at ambient temperature for 60 min. 
6. Chromophore Attachment 
The reaction was carried out at 25 μL, final concentrations reported. SrB-oA, (2x alkyne 
concentration), sodium ascorbate (1 mM), and copper (II) sulfate (1 mM) were added to samples 
which had been labeled with 1. The reaction was performed at ambient temperature for 60 
minutes. 
7. Gel Assay 
Labeled samples were diluted to 35 μL with gel-loading buffer. ACPs and KSATs were 
separated by 12.5% SDS-PAGE with 5% stacking gel (100 V, 50 mA, 135 min). SpnB was 
separated by 4 – 20% gradient HEPES-PAGE (100 V, 50 mA, 90 min). Gels were developed in 10% 
acetic acid to visualize Srb-oA. Srb-oA labeled proteins were imaged on a BioDoc-It Imaging 
System with UVtransilluminator. Total protein was stained using GelCode Blue. 
8. Proteolysis 
Promega Sequencing Grade Modified Trypsin was added to prepared samples so that the final 
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trypsin:ACP ratio was 1:50 (w/w). The mixture was incubated at 30°C for 18 hours. Digestion was 
quenched by addition of an equal volume of 10% formic acid. Digests were flash frozen in N2(l) 
and stored at -20°C until analysis. 
9. LC-MS 
Separation was performed with a Waters 1525 system. The gradient employed was A = water + 
0.1% formic acid, B = acetonitrile + 0.1% formic acid, 5-95% B over 60 min with a Vydac 218TP 
C18 5u column (4.6 x 150 mm). Mass spectra were acquired with a Waters Micromass ZQ mass 
detector in EI+ mode: Capillary voltage = 3.50 kV, cone voltage = 30 V, extractor = 3 V, RF lens = 
0.0 V, source temp = 100°C, desolvation temp = 200°C, desolvation gas = 300 L/hr, desolvation 
gas = 0.0 L/hr The system was operated and spectra were processed using the Waters Empower 
software suite. 
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CHAPTER 3 
β-LACTAMS AS VERSATILE REAGENTS FOR ACYL CARRIER PROTEIN LABELING 
3.1 Introduction 
As introduced in the previous chapter, we began with a simple idea of using electrophilic 
β-lactones as acylating agents for ACPs.
1
 Our hypothesis was that the resulting ACP-bound β-
hydroxythioester would represent a common structural motif in modular polyketide 
biosynthesis . A panel of the substituted lactones was examined for selectivity for the Ppant-
thiol over competing nucleophiles, including the KS active site. All of the lactones investigated 
showed some level of Ppant-acylation ,monosubstituted β-lactones were generally both more 
reactive and selective. However, it emerged that even the best acylating agents required a very 
large excess to obtain saturation of the ACPs, indicating that the reactivity of lactones needed 
improvement.  With limited scope of structural modifications given the lactone structure, we 
were compelled to consider alternate electrophiles for future experimentation. With the 
purpose of improving upon the reactivity of β-lactones, we explored the idea of using β-lactams 
as electrophilic parners for ACPs. A series of N-activated β-lactams were prepared to examine 
site-specific acylation of the phosphopantetheine-thiol. 
An initial concern was that increased reactivity may result in higher off-target 
interactions with competing nucleophiles, such as the KS-active site, and decreased selectivity 
for the targeted Ppant group. To circumvent competition from other nucleophiles for initial 
experimentation, we adapted the use of separated stand-alone domains of ACP and KS-AT
2-5
, as 
introduced and discussed in Chapter 1. The separated domains retain their function when 
reintroduced in vitro. As a result, the challenge of designing Ppant-acylating agents is reduced to 
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one of selectivity for holo-ACP over apo-ACP alone since the KS domain can be introduced after 
ACP-loading has occurred without limiting the scope of its utility. 
In this manner, by using separated domains, we began to explore β-lactams as thiol -
reactive acylating agents for isolated ACP domains. Relative to β-lactones, the amide nitrogen of 
β-lactams offers an additional site for ring substitution that is electronically coupled to the 
carbonyl, thus providing a reliable means of tuning electrophilicity. The experimental set-up 
descrbed here is used to establish N-activated β-lactams as efficient and versatile acylating 
agents for ACP domains. Further along, we wished to increase our understanding of KS-ACP 
recognition and intermodular polyketide transfer between these components, for which, 
fluorescence and affinity labeling applications were designed. 
3.2 Results and discussion 
β-lactams were employed as electrophilic partners as they were expected to have a 
reactive advantage relative to β-lactones through appropriate activation of the ring nitrogen.
 6
 
To test this hypothesis, a panel of diverse β-lactams were prepared by introducing common 
nitrogen -protecting groups onto the parent azetidinone (compound 1) via established methods 
to produce compounds 2–5 (Figure 13.)
7-10
.To establish the extent of acylation, saturation 
curves were generated by varying the number of equivalents of each lactam relative to isolated 
Figure 13.  N-activated β-lactams 
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holo-ACP2 (module 2) and holo-ACP3 (module 3) from 6-deoxyerythronolide B synthase (DEBS) 
in analogous fashion to our previous work with β-lactones.
1
 In general, it was performed by 
incubating the ACP with the lactam for 1 h at room temperature. The mixture was subjected to 
trypsin digestion and subsequently quenched with formic acid. The resulting array of peptide 
fragments was analyzed by LC-MS (Figure 14). The extent of loading was estimated from the 
ratio of acylated Ppant-containing peptide to total Ppant-containing peptide , assuming similar 
ionization potentials. Acylation experiments showed that compounds 2–5 exhibited excellent 
acylation efficiencies with both holo-ACPs(Table 2,3). All compounds, with exception of Boc-
activated lactam(compound 5), showed around 80% loading at a low 10 equivalents (Figure 14.). 
To demonstrate the benefit of using lactams, a direct competition between compound 6 and the 
most reactive β-lactone from our previous study, 4-methyloxetan-2-one was performed by 
treating ACP2 simultaneously with 10 equivalents of each for 1 h. The acylated-ACP was 
trypsinized and the resulting peptide fragments were analyzed by LC-MS which clearly 
demonstrates a reactive advantage of β-lactams for acylation of holo-ACP (Figure 15.).  Again, in 
ACP2 ACP3 
Figure 14. Saturation curves for β-lactam loading  
Determined by tandem proteolysis-mass spectrometry for ACP2 (Top) and ACP3 (Bottom) with 
compounds 2-6. Equivalents of lactam are per protein molecule. Lines are added for clarity. 
Error bars represent one standard deviation (n=3). 
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the absence of any solvent-exposed cysteine residues, the Ppant-thiol is the only competent 
nucleophile present as these ACP.  
Table 2. ACP2 loading with β-lactams 
Equivalents 
Compound 2 Compound 3 Compound 4 
   
St. 
Dev 
Avg. 
   
St. Dev Avg. 
   
St. Dev Avg. 
0.5 12.3 15.0 18.9 2.7 15.3 9.3 12.0 13.9 1.9 11.6 27.0 29.0 23.0 2.5 26.4 
1.0 50.2 54.2 56.1 2.4 53.3 21.1 23.7 24.3 1.4 22.8 47.2 51.8 44.0 2.5 47.8 
5.0 78.5 79.9 85.6 2.9 81.6 82.3 85.4 89.0 2.7 85.0 73.5 68.0 76.9 3.2 72.8 
10.0 80.5 83.4 89.6 3.8 84.5 84.4 92.0 93.0 3.8 90.0 82.0 85.4 78.0 3.0 81.9 
20.0 84.5 92.4 93.0 3.9 89.9 90.4 95.4 96.4 2.7 94.0 88.1 90.0 94.7 2.7 91.0 
50.0 92.0 93.6 96.5 1.9 94.0 94.5 98.7 99.5 2.2 97.5 92.0 98.4 98.0 2.9 96.1 
                
Equivalents 
Compound 5 Compound 6 
     
   
St. 
Dev 
Avg. 
   
St. Dev Avg. 
     
0.5 2.1 2.9 4.8 1.1 3.3 10.4 12.0 13.4 1.2 11.9 
     
1.0 7.5 8.9 11.1 1.4 9.2 26.0 29.0 30.6 1.9 28.5 
     
5.0 9.8 15.3 15.8 2.7 13.7 65.2 69.0 72.9 3.1 69.0 
     
10.0 36.7 39.8 45.9 3.9 40.8 91.1 94.9 96.0 2.1 94.0 
     
20.0 68.7 70.4 76.3 3.2 71.7 96.2 98.9 99.5 1.5 98.3 
     
50.0 98.4 97.8 93.1 2.8 96.6 96.8 98.9 99.8 2.4 98.6 
     
Figure 15. β-lactams vs. β-lactone ACP-acylation 
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Table 3. ACP3 loading with β-lactams 
Equivalents 
Compound 2 Compound 3 Compound 4 
      St. Dev Avg.       St. Dev Avg.       St. Dev Avg. 
0.5 41.6 39.8 42.9 1.2 41.9 18.6 21.0 22.5 1.6 20.7 18.0 16.5 13.0 2.1 15.8 
1.0 58.0 59.9 56.0 1.6 57.9 42.1 43.7 44.4 1.0 43.3 38.0 41.0 36.0 2.1 38.2 
5.0 62.5 64.6 66.2 1.5 64.4 52.5 55.8 56.9 1.9 55.1 46.0 44.0 45.8 0.9 45.2 
10.0 73.1 77.4 84.3 4.6 78.3 78.0 85.8 86.2 3.8 83.2 76.0 71.0 80.0 3.7 75.6 
20.0 80.2 81.9 83.7 1.4 82.0 89.9 89.7 95.7 2.8 91.8 85.0 79.0 89.0 4.1 84.4 
50.0 81.4 85.8 88.3 2.9 85.0 94.8 98.9 99.4 2.4 98.1 27.0 29.0 23.0 3.7 94.7 
                
Equivalents 
Compound 5 Compound 6 
           St. Dev Avg.       St. Dev Avg. 
     0.5 5.2 6.0 7.2 0.8 6.0 11.4 12.1 14.2 1.2 12.5 
     1.0 14.0 13.4 16.0 1.1 14.5 28.6 32.0 33.1 1.9 31.1 
     5.0 24.5 28.0 30.2 2.3 27.6 75.6 81.2 83.1 3.1 79.4 
     10.0 55.0 61.0 68.4 5.5 61.4 83.1 86.9 87.9 2.1 85.8 
     20.0 67.5 72.9 74.1 2.9 71.4 89.4 92.0 93.2 1.5 91.6 
     50.0 89.4 94.3 98.0 3.5 93.9 90 94 95.6 2.4 93.4 
       
 A gel-based fluorescent assay was used, based on work by Sieber and coworkers, to 
further amine selectivity for holo- over apo-ACP
11
. A [3 + 2] cycloaddition (click reaction) was 
used for coupling acylated ACPs to a rhodamine-based fluorophore.
12–14
 ACP2 and ACP3 (both 
holo and apo) were mixed with 1, 5, and 10 equivalents of 6 and reaction continued at room 
temperature for 1 h. The click step was performed with addition of Rhodamine azide along with 
all necessary click reaction components and the resulting protein products were analyzed via 
SDS-PAGE . Bright bands were observed for the holo-ACPs while apo-ACPs provided only 
background fluorescence (Figure 16.). Remarkably, fluorescence can be easily observed at an 
impressive 5 equivalents of lactam for both ACPs, indicating the extent of reactivity.  
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In order to explore Ppant selectivity and further demonstrate utility of the alkyne 
handle, we turned our focus to mixtures of apo and holo ACP2. We wanted to test whether 
holo-ACP2 could be isolated from a mixture of apo and holo by an affinity label conjugated to 
compound 6. A biotin -streptavidin interaction was used as on bio-orthagonal agent for ACP 
purification as this system (1) has been used extensively for protein separations
15–18
 and (2) 
relies  on a small molecule that we envisioned could readily be conjugated to the lactam 
warhead. As proof of principle and to assess the efficiency of each step, we began with samples 
of pure holo-ACP. Initially, attempts to pre-conjugate compound 6 with the biotin azide followed 
by 1 h reaction with the ACP resulted in low yields of the acylated protein . Another observation 
was competition from other proteinaceous nucleophiles for longer reaction times which forced 
us to consider an alternative order of addition.  
Figure 16. Fluorescence SDS-PAGE analysis of DEBS ACP2 and ACP3 
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The [3 + 2] cycloaddition of the biotin azide with pre-acylated holo-ACP resulted in 30% 
recovery following streptavidin–sepharose binding and subsequent treatment of the bound 
material with hydrazine, which restores the Ppant-thiol via nucleophilic attack on the thioester 
carbonyl. However, the samples has to be subjected to filtration twice prior to treatment with 
the streptavidin beads, to remove excess lactam and biotin following the initial acylation and 
subsequent [3 + 2] cycloaddition. The protein concentration was analyzed at each stage which 
revealed that the primary source of ACP loss in the process was these filtration steps. In fact, 
more than 60% of the protein subjected to the streptavidin was recovered upon treatment with 
(top) an initial 80:20 (holo:apo) mixture of ACP2 and (bottom) the result of β-lactam based 
purification of holo-ACP2.  The lack of apo-ACP2 in the latter indicates that the β-lactam 
(compound 6) is highly selective for holo-ACP2  
Figure 17. Whole protein mass spectra of ACP2 purification strategy 
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hydrazine while almost half of the initial mixture is lost to the filtration membrane before this 
step. It is expected that upon scale-up, where small losses of protein to filtration are less 
significant, percent recovery will be drastically improved. As proof of principle, however, we 
were confident that these recovery levels would suffice for further experimentation. 
 The holo (Ppantylated)-form of ACP is resulted due to overexpression of ACP in BAP1, 
an engineered strain of E. coli with a phosphopantetheinyl transferase embedded in the 
genome. However, as expression levels increase, the transferase performance suffers resulting 
in mixtures of holo- and apo-ACP. We examined the viability of our approach for separating 
holo- from apo-ACP with a 80 : 20 (holo : apo) mixture of ACP2, a typical ratio observed from 
overexpression of ACP in BAP1, and subjected it to the same process described above. Analysis 
of the final solution obtained from hydrazine treatment of the bound material by LC-MS 
revealed only holo-ACP2 (Figure 17.). Taken together with the fluorescence assay, these 
experiments nicely illustrate the remarkable Ppant-selectivity and versatility of compound 6.  
We wanted to confirm that the purification process did not alter the protein structure. It 
was confirmed by examining the ability of eluted holo-ACP2 to accept a methylmalonyl-CoA unit 
from an acyltransferase. Methylmalonyl-CoA and purified holo-ACP was added to a buffered 
solution of DEBS module 6 ketosynthase-acyltransferase didomain
5,19-21
 ([KS6AT6]). After 30 min 
of reaction time, the mixture was subjected to trypsinolysis and the resulting peptide fragments 
were separated and analyzed via LC-MS (Figure 18.). The prominent peak at 809.1 mass units 
suggests that the purified ACP remains competent for AT-ACP methylmalonate transfer as seen 
previously.
21
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In this manner, it was established that carrier proteins could be efficiently acylated with 
β-lactams. However, to demonstrate the utility of these reagents for PKS examination, a direct 
comparison to traditional small molecule probes was necessary. In particular, we were 
interested in ACP to KS transfer of the β-aminothioester product (Figure 19.). Polyketide 
intermediate transfer between ACP and KS plays a critical role in product generation for all PKS 
systems and acts as a primary determinant for proper flow of intermediates during polyketide 
biosynthesis. As discussed in Chapter1, N-acetylcysteamine thioester (SNAc) mimics the terminal 
portion of the Ppant group and is most commonly used for direct acylation of KS active sites.
22–25
 
A gel-based fluorescence assay was employed to qualitatively determine the kinetic competency 
of our lactam -derived acyl-ACPs, relative to propionyl-SNAc and the potent KS-inhibitor, 
cerulenin
26
.  
Acylation of holo-ACP2 was executed as before using 10 equivalents of compound 6 
followed by Cu-mediated [3 + 2] cycloaddition with rhodamine azide. The resulting acyl-ACP was 
incubated with [KS6AT6] for 1 h at room temperature with or without competing KS-
acylating/alkylating agents to explore ACP to KS transfer (Figure 20.). From these data , it is clear 
Figure 18. Mass spectrum of methylmalonyl-CoA transfer to purified ACP 
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that fluorescence transfers from the ACP to KS in the absence and presence of both cerulenin 
and propionyl-SNAc, indicating that the lactam -derived acyl-ACPs are, at a minimum, 
competitive with traditional small molecule probes (Lanes 2, 4, and 6). The lack of KS-
fluorescence observed when [KS6AT6] is pre-treated with each competitor (Lanes 3 and 5) 
confirms that transfer is occurring between the Ppant arm and KS active site. Finally, the 
absence of a fluorescent band when [KS6AT6] is treated directly with the compound 6-
rhodamine click product implies that the ACP is required for transfer to occur (Lane 7). In all, 
these results suggest that β-lactam-derived, acyl-ACPs behave in analogous fashion to natural 
polyketide intermediates and are kinetically competitive with traditional PKS probes and 
inhibitors . Further experimentation to quantitatively determine the transfer rate is currently 
ongoing in the lab but, at this point, it is clear that  activated β-lactams offer a greatly simplified 
and readily adaptable set of carrier protein modifiers. 
 
Figure 19. Schematic for fluoroscence assay for ACP to KS acyl transfer.   
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3.3 Conclusion 
In summary, we have demonstrated the utility of N-activated β-lactams for acylation of 
holo-ACPs. The structures examined are significantly more reactive than the β-lactones that we 
have previously reported and all are available in a single synthetic step from commercially 
available starting materials. Both carbamate and sulfamate moieties effectively activate the 
lactam ring for ACP-acylation. The resulting acylation products maintain the thioester linkage 
common to all polyketide biosynthetic intermediates and the reaction can be readily reversed 
by treatment with hydrazine.  
The applications of β-lactams demonstrated so far just begin to scratch the surface of 
their capabilities. The N-propargyloxycarbonyl group (compound 6) provides a versatile chemical 
handle for nearly limitless elaboration of structure. Although we have focused exclusively on 
proteins involved in polyketide biosynthesis , we expect the general thiol -reactivity of these 
simple β-lactams to translate well to other systems bearing natural or engineered thiols. 
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(Top) Fluorescent ACP2 (ACP*) is prepared via click coupling of rhodamine azide with 
ACP2, preacylated with compound 6.  ACP2* is then incubated with [KS6AT6] under 
various conditions. Lanes are marked with the corresponding components for each 
reaction. 
1
[KS6AT6] was mixed with competitor (cerulenin or propionyl-SNAc) for 1 hour 
prior to addition of ACP* (Lanes 3 and 5). 
2
ACP* and competitor were introduced to 
[KS6AT6] simultaneously (Lanes 4 and 6). 
3
[KS6AT6] was mixed with 10 eq of the click 
product in the absence of ACP2 (Lane 7). SNAc = N-acetylcysteimine. (Bottom) PAGE full 
gel stain.  
Figure 20. Fluorescent competition assay for ACP to KS acyl transfer. 
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3.4 Experimental Details 
Synthesis 
1-[(4-Methylphenyl)sulfonyl]azetidin-2-one
27
 (2). 2-Azetidinone (72 mg, 1 mmol) was dissolved 
in THF (5 mL) at −78 °C. NaHDMS (367 mg, 2 mmol) dissolved in THF (1 mL) was added in 
portions. 4-Toluenesulfonyl chloride (763 mg, 4 mmol) dissolved in THF (5 mL) was added to the 
reaction mixture in portions slowly over 15 min. The reaction mixture was stirred until all the 
starting material was consumed (monitored by TLC ), approximately 8 h. The reaction was 
washed with sodium bicarbonate (10 ml ×3) and extracted with DCM (25 mL ×3). The combined 
organic layers were dried over Na2SO4, and the solvent was removed by rotary evaporation . The 
crude material was purified by flash chromatography with 1 : 1 hexane : ethyl acetate. Yield: 
(178 mg, 0.79 mmol) 79% of final product as colorless solid.  
1
H NMR (400 MHz, CDCl3) δ: 7.9–7.87 (d, J = 8.29, 2H), 7.32–7.41 (d, J = 8.48, 2H), 3.67–3.64 (t, J 
= 5.2, 2H), 3.06–3.02 (t, J = 5.1, 2H), 2.46 (s, 3H).
13
C NMR (400 MHz, CDCl3) δ: 161.9, 143.4, 
128.3, 125.7, 38.0, 34.9, 19.9. IR : ν 2973, 1776, 1362, 1154, 682, 98 cm
−1
, MS [M + H]
+
 = 227 
Benzyl 2-oxoazetidine-1-carboxylate
8
 (3). HDMS (250 mg, 1.5 mmol) was dissolved in THF (8 
mL) and cooled to −78 °C. nBuLi (96 mg, 1.5 mmol) was added dropwise and stirred for 30 min. 
In a separate RBF, 2-azetidinone (106.6 mg, 1.5 mmol) was dissolved in 5 mL of THF at −78 °C. 
The contents of the first flask were transferred via cannula to the second flask and stirred for 1 
h. Benzylchloroformate (256 mg, 1.5 mmol) was added in portions and stirred for 2 h at −78 °C. 
The reaction mixture was allowed to warm to ambient temperature and stirred for an additional 
4 h. The reaction mixture was diluted with water and extracted with DCM (50 mL × 3). 
Combined organic phases were washed with brine and dried over Na2SO4. Solvent was removed 
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by rotary evaporation . Purification of crude product by flash chromatography with 5 : 1 hexane
: ethyl acetate yields (285 mg, 1.39 mmol) 93% of product as an oil.  
1
H NMR (400 MHz, CDCl3) δ: 7.28–7.16 (m, 5H), 5.1 (s, 2H), 3.44–3.4 (t, J = 5.3, 2H), 2.85–2.81(t, J 
= 5.3, 2H).
13
C NMR (400 MHz, CDCl3) δ 23.7, 34.7, 36.1, 65.9, 126.1, 126.8, 147.1, 155.0, 167.8. 
IR : ν 3040, 2985, 1811, 1724, 1388, 1330, 1214, 1177, 1120, 1044, 763, 699 cm
−1
, MS [M + H]
+
 = 
206 
(9H-Fluoren-9-yl)methyl 2-oxoazetidin-1-carboxylate (4). 2-Azetidinone (72 mg, 1 mmol) was 
dissolved in THF (5 mL), and LiHDMS (167 mg, 1 mmol) dissolved in THF (2 mL) was added 
dropwise at −78 °C over a 15 min period and stirred for an additional 30 min. 9-Fluorenylmethyl 
chloroformate (259 mg, 1 mmol) dissolved in THF (2 mL) was added dropwise at −78 °C. The 
resulting mixture was stirred for 1 h at −78 °C, then allowed to warm to R.T, and stirred for 1 h 
further at which point the starting material had been completely consumed (monitored by TLC ). 
The reaction mixture was poured into water and extracted with DCM (3 × 25 mL). The combined 
extracts were washed with brine and dried over Na2SO4. After removal of the solvent by rotary 
evaporation , the crude reaction mixture was purified by flash chromatography with DCM : ethyl 
acetate, 95 : 5, producing the product as an off-white solid (62 mg, 0.62 mmol) in 86% yield.  
1
H NMR (400 MHz, CDCl3) δ 3.13 (t, 2H), 3.68 (t, 2H), 4.32 (t, 1H), 4.47 (d, 2H), 7.26–7.80 (m, 8H). 
13
C NMR (400 MHz, CDCl3) δ 162.1, 148.3, 141.3, 139.4, 126.4, 125.5, 123.5, 118.1, 66.8, 44.3, 
34.8, 36.2. IR : ν 3015, 2922,1770, 1722, 1449, 1388, 1313,1119, 1044, 964, 738 cm
−1. 
HRMS (EI+) 
Calcd for C18H15NO3, 293.1052; Found, 293.1046 
tert-Butyl 2-oxoazetidine-1-carboxylate
28
 (5). 2-Azetidinone (72 mg, 1 mmol) and DMAP (12.2 
mg, 0.1 mmol) were dissolved in acetonitrile (5 mL) at 0 °C. Di-tert-butyl dicarbonate (218 mg, 
1.1 mmol) was added to the reaction mixture in portions. The reaction mixture was stirred at 0 
°C for 2 h, allowed to warm to ambient temperature and stirred overnight. The reaction mixture 
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was diluted with ethyl acetate and washed with 1 N aq. HCl and brine. The aqueous layer was 
extracted with ethyl acetate (25 mL ×3). Combined organic layers were dried over Na2SO4 and 
the solvent was removed by rotary evaporation . The crude product was purified by flash 
chromatography using 2 : 1, hexanes : ethyl acetate (154 mg, 0.9 mmol) 90% of product as an 
oil.  
1
H NMR (400 MHz, CDCl3) δ: 3.56–3.52 (t, J = 5.1, 2H), 3.03–2.87 (t, J = 5.2, 2H), 1.5 (s, 9H). 
13
C 
NMR (400 MHz, CDCl3) δ: 205.4, 162.1, 146.5, 81.2, 36.8, 35.0, 29.8, 26.2. IR : ν 2984, 1795, 
1719, 1331, 1157, 1043 cm
−1
, MS [M + H]
+
 = 172 
Prop-2-yn-1-yl 2-oxoazetidine-1-carboxylate (6). 2-Azetidinone (107 mg, 1.5 mmol) was 
dissolved in THF (7 mL) at −78 °C. LiHDMS (330 mg, 2 mmol) dissolved in THF (2 mL) was added 
in portions over 10 min and the reaction mixture was stirred for 30 min. Propargyl 
chloroformate (181 mg, 1.5 mmol) dissolved in THF (2 mL) was added in portions over 10 min 
and the reaction mixture was stirred at −78 °C for 2 h then allowed to warm to ambient 
temperature. The reaction mixture was diluted with water and extracted with DCM (50 mL ×3). 
The combined organic layers were washed with brine and dried over Na2SO4. Solvent was 
removed by rotary evaporation . Purification of crude product by flash chromatography with 95
: 5 DCM : methanol yields (106 mg, 0.69 mmol) 46% of product as a pale yellow solid. 
1
H NMR (400 MHz, CDCl3) δ 4.82–4.81(d, J = 23.3, 1H), 3.68–3.65 (t, J = 5.3, 2H), 3.10–3.07 (t, J = 
5.3, 2H), 2.55–2.53 (t, J = 2.4, 1H). 
13
C NMR (400 MHz, CDCl3) δ 34.9, 36.1, 51.8, 74.0, 146.3, 
162.2. IR : ν 3251, 2925, 2134, 1782, 1722, 1313, 1187, 1114, 1045, 615 cm
−1. 
HRMS (EI+) Calcd 
for C7H7NO3, 153.0426; Found, 153.0402 
Sulforhodamine-B azide (S1)
1
. 3-Azido-1-aminopropane
29
 (22 mg, 0.22 mmol) and triethylamine 
(51 mg, 0.5 mmol) were dissolved in 1 mL of 5 : 1 DCM : DMF and cooled to 0 °C. 
Sulforhodamine B, sulfonyl chloride [mixture of ortho- and para- sulfonyl chloride isomers] (115 
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mg, 0.20 mmol) was added portion-wise over ca. 30 min and stirred overnight at room 
temperature. Solvent was removed in vacuo, and the product was purified by flash 
chromatography over silica gel with 90 : 5 : 5 DCM : acetonitrile : methanol mobile phase . The 
ortho isomer was distinguished by its reversible color change in pH 9.0 buffer .
30
para Isomer: (22 
mg 0.034 mmol) 17%, ortho isomer (18 mg, 0.028 mmol) 14%. Both obtained as a red solid with 
a metallic green luster. The ortho isomer was found to perform best in the click reaction and 
was utilized for labeling experiments.  
NMR spectra are of poor quality due to long relaxation times. Product is pure by LC-MS . IR : ν 
2975, 2100, 2590, 1339, 1180 cm
−1 
HRMS (EI+) Calcd for C30H37N6O6S2, 641.2210. Found, 
641.2216. 
Biotin azide (S2). D(+)-biotin (73 mg, 0.300 mmol) was dissolved in 3 mL of DMF by briefly 
heating the mixture with a heat gun. The mixture was cooled to 0 °C in an ice-water bath and 6-
chloro-1-hexanol (120 mg, 0.900 mmol), and N,N-dimethylamino pyridine (73 mg, 0.600 mmol) 
were added. N-(3-Dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (115 mg, 0.600 
mmol) was added in portions over ca. 60 min and the reaction mixture was allowed to come to 
room temperature. Stirring was continued for 24 h. When biotin had been consumed 
(monitored by TLC ), the reaction mixture was diluted with ethyl acetate (100 mL). The organic 
phase was washed with concentrated NaHCO3 (3 × 50 mL), and pH 2 saturated Na2SO4 (5 × 50 
mL portions). Solvent was removed by rotary evaporation and the material was used without 
further purification . The material from the ester coupling was dissolved in 5 mL of DMF and 
NaN3 (40 mg, 0.600 mmol) and a catalytic amount of KI were added. A reflux condenser was 
attached and the reaction mixture was heated to 80 °C for 16 h. The material was diluted with 
100 mL of ethyl acetate and washed with brine. The solvent was removed by rotary evaporation 
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and the crude material purified by flash chromatography (5% MeOH in DCM) to yield 67 mg, 
0.182 mmol of product (61%) as a waxy pale yellow solid.  
1
H NMR (400 MHz, CDCl3) δ (ppm) 1.32–1.52 (m, 6 H) 1.56–1.80 (m, 8 H) 2.33 (t, J = 7.45, 2 H) 
2.74 (d, J = 12.76, 1 H) 2.91 (dd, J = 12.82, 4.99, 1 H) 3.16 (ddd, J = 8.34, 6.38, 4.74, 1 H) 3.28 (t, J 
= 6.88, 2 H) 4.06 (t, J = 6.63, 2 H) 4.31 (ddd, J = 7.67, 4.71, 1.14, 1 H) 4.51 (dd, J = 7.71, 5.05, 1 H) 
5.67 (s, 1 H) 6.03 (s, 1 H). 
13
C NMR (400 MHz, CDCl3) δ (ppm) 173.7, 163.7, 65.6, 61.2, 60.8, 56.1, 
51.3, 40.5, 33.9, 29.9, 28.7, 28.4, 27.2, 26.3, 25.5, 24.8. IR : ν 3230, 2934, 2101, 1733,1700, 1264, 
1175 cm
−1
HRMS (EI+) Calcd for C16H27N5O3S, 369.1848; Found, 369.1814 
Propionyl-N-acetylcysteamine (Propionyl-SNAc) To a solution of triethylamine (2.80 mmol) in 
dichlromethane (5 mL) was added propionic acid (1.40 mmol), (3-dimethylaminopropyl)-3-
ethylcarbodiimide hydrochloride (1.40 mmol), 1-hydroxybenzotriazole (HOBt) (1.40 mmol) and 
N-acetyl cysteamine (SNAc)(1.35 mmol). The reaction mixture was stirred overnight. The organic 
layer was washed with saturated NaHCO3 solution, 0.1 N HCl solution and brine. It was then 
dried over anhydrous sodium sulfate, concentrated under vacuum, and purified by flash column 
chromatography (1 : 1 hexane : ethyl acetate) to provide compound (140 mg, 74%) as a pale 
yellow oil.  
1
H NMR (400 MHz, CDCl3) δ (ppm) 0.86(t,J = 7.58 Hz, 3H) 1.69 (s, 3H) 2.28 (q, J = 7.4 Hz, 2H) 
2.72(t, J = 6.8 Hz, 2H) 3.07 (q, J = 6.6 Hz, 2H) 7.39 (br s, 1H).
13
C NMR (400 MHz, CDCl3) δ (ppm) 
199.4, 170.6, 39.0, 36.8, 28.0, 22.6, 9.4. IR : ν 3282,2979,1690,1650,1546,1373,1288,1090,935 
cm
−1
MS [M + H]
+
 = 176 
Protein expression and purification  
ACP2 was expressed from pNW06,
3
1 ACP3 was expressed from pVYA05.
5
 [KS6AT6] was 
expressed from pAYC11.
20
apo-ACPs were harvested from E. coli BL-21 and holo-ACPs were 
harvested from E. coli. BAP-1
32
 pNW6 and pVYA05 contain kanamycin resistant vectors.  
54 
 
 
General procedure for protein expression and isolation 
Bacteria were grown in 1 L shake cultures of LB-antibiotic media at 37 °C in an incubating shaker 
until the OD600 was between 0.6 and 0.8. Over expression was induced with 200 μL of 1 M IPTG 
(per liter of culture) and carried out at 18 °C for 18 h. After this point all work was carried out at 
4 °C. Cells were pelleted by spinning at 3000 RPM for 10 min and resuspended in 50 mL of lysis 
buffer (20 mM Tris-HCl, 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium 
pyrophosphate, 1 mM β-glycerophosphate, 1 mM sodium Na3VO4, 1 μg mL
−1
 leupeptin, pH 7.5). 
Cells were lysed using an ultrasonic converter. The lysate was pelleted at 10,000 rpm for 60 min. 
The supernatant was equilibrated with 3 mL of Ni-NTA slurry (per liter of culture) for 60 min by 
stirring with a PTFE-coated stir bar at minimal speed. The mixture was then poured into a fritted 
column and the supernatant eluted. The resin bed was washed with two 15 mL portions of wash 
buffer (50 mM phosphate, 300 mM NaCl, 20 mM imidazole , pH 8.0), and eluted with 3 mL (per 
liter of culture) of elution buffer (50 mM phosphate, 300 mM NaCl, 250 mM imidazole , pH 8.0). 
The purified protein was loaded into a 3 kDa NMW centrifugal concentrator and diluted to 15 
mL with storage buffer (100 mM Tris, 1 mM EDTA, 1 mM dithioerythritol, 10% glycerol pH 8) and 
spun until the final volume was ≤500 μL. Dilution and filtration was repeated a total of three 
times. Protein concentration was determined by Bradford assay with a BSA standard curve, 
average final concentration was approximately 3 mM. Proteins were flash frozen and stored at 
−80 °C until use.  
Proteins acylation with β-lactams 
Labeling reactions for gel assays were performed at 20 μL total volume, reactions for LC-MS 
were performed at 50 μL total volume. Final concentrations reported in procedure. Phosphate 
buffer (100 mM, pH 7), tris(2-carboxyethyl)phosphine (TCEP) (2.5 mM), and protein (0.025 mM) 
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were reacted at ambient temperature for 15 min. β-Lactam was added to achieve the 
appropriate final concentration (0.5, 1, 5, 10, 20, 50x) with respect to protein . The mixture was 
equilibrated at ambient temperature for 60 min.  
β-Lactam/β-lactone competition loading of ACP 
10 equivalents of compound 6 and 4-methyloxetan-2-one were mixed and introduced to 
buffered holo-ACP2 for 1 h. The sample was trypsinized analyzed by LC-MS as described 
previously.
1
  
Chromophore attachment 
The reaction was carried out at 25 μL, final concentrations reported. S1, (2× with respect to 6), 
sodium ascorbate (1 mM), and copper(II) sulfate (1 mM) were added to samples which had been 
labeled with 6. The reaction was performed at ambient temperature for 60 min.  
Gel assay 
Labeled samples were diluted to 35 μL with gel-loading buffer . ACP 2 was separated by 12% and 
ACP 3 with 15% SDS-PAGE , each with a 5% stacking gel run at 100 V, 50 mA, 135 min. Gels were 
developed in 10% acetic acid to visualize S1. Labeled proteins were imaged on a UV-
transilluminator. Total protein was stained using Coomassie stain. For the ACP to KS transfer 
experiments (Figure. 8), proteins were separated using a 4–20% gradient HEPES-PAGE gel (100V, 
50mA, 90 min).  
Proteolysis  
Sequencing grade modified trypsin was added to prepared samples so that the final trypsin :
ACP ratio was 1 : 50 (w/w). The mixture was incubated at 30 °C for 18 h. Digestion was 
quenched by addition of an equal volume of 10% formic acid. Digests were flash frozen in liquid 
nitrogen and stored at −20 °C until analysis.  
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Affinity purification of holo-ACPs 
Lactam modification of ACPs 
 Unless otherwise stated, phosphate buffer refers to 100 mM, pH 7.0 phosphate. 1 mL of an 80 :
20 mixture of holo : apo-ACP2 (25 μM total protein ) was equilibrated at ambient temperature 
for 15 min in phosphate buffer containing 2.5 mM TCEP. 6 (25× with respect to total ACP 
concentration) was added and the mixture was equilibrated at ambient temperature for 1 h. To 
remove excess 6, the mixture was loaded into a 3kDa NMW concentrator and the volume 
reduced to 100 μL by spinning in a centrifuge cooled to 4 °C. The mixture was diluted to 500 μL 
with phosphate buffer , and then concentrated to 100 μL again. This process was repeated a 
total of 3 times. Protein was removed from the concentrator by inverting it and spinning . The 
concentrator was then washed several times with phosphate buffer which was added to the 
protein sample. The filtered protein was reconstituted to 900 μL.[3 + 2] Cycloaddition In a 
separate microfuge tube, DMSO (100 μL), S2 (50× with respect to protein ), THPTA
33
(1.1 mM), 
NaAsc (10 mM), and CuSO4 (1 mM) were combined. Best results are obtained if these reagents 
are first combined in a separate container and then added to the protein . The combined click 
reagents are added to the protein from the previous step and allowed to react at ambient 
temperature for 6 h. Excess biotin reagent was removed using the same procedure for the 
removal of excess lactam . The modified protein was reconstituted to 1000 μL in phosphate 
buffer . 
Immobilization of modified ACPs  
Streptavidin Sepharose High Performance (10× with respect to protein ) was washed 3× with 
1000 μL of phosphate buffer and the supernatant was removed. The modified protein from the 
previous step was added to the beads, and the mixture equilibrated at ambient temperature for 
60 min with agitation on an orbit shaker. The supernatant was removed and the beads were 
57 
 
washed 5× with 1000 μL of phosphate buffer , 5× with 1000 μL of TRIS buffer (100 mM, pH 9.0), 
and once with 1000 μL of 100 mM TRIS, +10 mM N2H4, pH 9.0. 
Elution of immobilized ACPs  
The washed beads from the previous step were resuspended in 1000 μL of 100 mM ammonium 
formate containing 100 mM N2H4 (100 mM pH 9.0) and equilibrated overnight at 4 °C with 
agitation on an orbit shaker. Eluted protein was concentrated in a 3kDa NMW concentrator and 
subjected to buffer exchange for further experiments, or combined with TCEP for direct infusion 
LC-MS experiments. 
Fluorescent assay for ACP to KS transfer 
Holo-ACP2 (25 μM) was labeled with 10 equivalents of 6 followed by [3 + 2] cycloaddition with 
S2 as described above. For transfer of the fluorescent product, [KS6AT6] (25 μM) was 
introduced to acyl-ACP2 (25 μM) and incubated for 1 h. For lanes 3 and 5 (Figure. 9), [KS6AT6] 
was pretreated with cerulenin (5 mM) or propionyl SNAc (10 mM) for 1 h before introducing it 
to acyl-ACP2. For lanes 4 and 6, acyl-ACP2 (25 μM) was mixed with cerulenin (5 mM) or 
propionyl-SNAc (10 mM) followed by 1 h incubation with [KS6AT6] (25 μM). The [KS6AT6] 
control (lane 7) was executed under the same acylation and click conditions as in other samples 
but without the ACP or small molecule competitors.  
LC-MS  
Separation was performed with a Waters 1525 system. The gradient employed was A = water + 
0.1% formic acid, B = acetonitrile + 0.1% formic acid, 5–95% B over 60 min with a Waters 
XBridge C18 5u column (4.6 × 150 mm). Mass spectra were acquired with a Waters Micromass 
ZQ mass detector in EI+ mode: Capillary voltage = 3.50 kV, cone voltage = 30 V, extractor = 3 V, 
RF lens = 0.0 V, source T = 100 °C, desolvation T = 200 °C, desolvation gas = 300 L h
−1
, 
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desolvation gas = 0.0 L h
−1
 The system was operated by and spectra were processed using the 
Waters Empower software suite. 
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CHAPTER 4 
A MECHANISM-BASED FLUORESCENT TRANSFER ASSAY FOR EXAMINING KETOSYNTHASE 
SELECTIVITY 
4.1. Introduction 
As discussed in detail in earlier chapters, the field of polyketide engineering has faced a 
constant struggle to overcome often strict substrate selectivities of the critical biosynthetic 
enzymes.
1–7
 In case of modular PKS systems, the polyketide product flow along the assembly line 
is governed by shuttling of intermediates between the acyl carrier protein (ACP) and 
ketosynthase (KS) domains (Figure 21.).
8-11
 The KS occupies a central role in this crucial process 
and has been the focus of numerous studies with the hopes of both establishing a better 
understanding of natural systems and improving our ability to manipulate them.
12–15
 In its 
simplest form, this requires a means of accurately differentiating between substrates that 
acylate the KS active site-cysteine and those that do not. 
A polyketide intermediate is passed from an upstream ACP to a downstream KS via the 
phosphopantetheine arm of holo-ACP.  Often the substrate selectivity of the acceptor KS 
domain determines the efficiency of this process and controls the flow of intermediates 
down the assembly line.  KS = ketosynthase, ACP = acyl carrier protein, AT = acyltransferase, 
DH = dehydratase, ER = enoyl reductase, KR = ketoreductase. 
Figure 21. Intermodular transfer in modular polyketide synthases.   
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As described previously, radiolabelling traditionally used to examine KS active site 
loading has significant drawbacks, including limited scope, reproducibility, and cost that can 
severely constrain the scope of such analyses. More recently, a number of groups have 
developed mass spectrometry-based techniques for examining KS active site acylation.
13,14,16
 
One particularly popular approach utilizes tandem proteolysis/LC-MS to tease out differences in 
loading propensities for various substrates. Despite the many advantages compared to 
radiolabeling, MS-based methods still suffer from a number of important shortcomings. It is 
abundantly clear that techniques capable of providing easy and reliable access to KS selectivity 
profiles are essential for continued progress in this field.  
With hosts of new biosynthetic systems being uncovered with constant advances in genomic 
mining, the need for simple, cost-effective means of characterizing them has never been 
greater. We were interested to develop an alternative means of directly determining KS 
substrate selectivity using readily accessible, inexpensive reagents and equipment. Such a 
method would greatly facilitate the process of high-throughput PKS investigation and allow for 
broadened exploration of the rules of substrate recognition that govern small molecule output. 
Subsequent conjugation of modified ACP to a fluorophore (red star) uses standard click 
chemistry.  The resulting fluorescent ACP is used as the fluorescence donor in the current 
study. 
Figure 22. Site-selective ACP-acylation using N-activated β-lactams.   
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As discussed in earlier chapters, we have recently developed a series of β-lactone and β-
lactam probes capable of directly acylating the Ppant-thiol of holo-ACPs.
17,18
 Incorporation of an 
alkyne functionality provides a chemical handle for conjugation with fluorophores (Figure 
22.).The thioester-ACP resulting from incubation of holo-ACP with a propargyloxycarbonyl (Poc)-
activated β-lactam was shown to be competitive with traditional N-acetylcysteamine (SNAc) 
thioesters for KS acylation. Based on these results, it occurred to us that fluorescent thioester-
ACPs, derived from an alkyne-bearing β-lactam, coupled with acyl-SNAc compounds, could 
provide a straightforward means of examining KS selectivity in whole PKS modules. More 
specifically, the degree of KS acylation for a given SNAc substrate may be assayed by introducing 
a fluorescent ACP after incubation of KS and substrate and monitoring fluorescence transfer via 
gel electrophoresis. The amount of fluorescence transfer would therefore indicate to what 
extent the SNAc compound was accepted by the KS domain (Figure  23.). High KS-loading would 
block subsequent fluorescence transfer from ACP, and thus produce little to no fluorescent 
A given KS domain is incubated with acyl-SNAc followed by addition of fluorescently labeled 
ACP.  The amount of fluorescence transferred from the ACP to the KS active site provides a 
direct readout of the substrate tolerance for each acyl-SNAc examined. KS = ketosynthase, ACP 
= acyl carrier protein, AT = acyltransferase, SNAc = N-acetylcysteimine.  
Figure 23. Schematic of mechanism-based, fluorescence transfer assay for KS-selectivity 
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signal in the gel. Alternatively, insufficient KS-acylation with a SNAc compound would leave most 
KS active sites free to accept the fluorescent substrate from ACP resulting in a bright band. This 
technique would afford a direct measure of KS selectivity while circumventing the limitations of 
mass spectrometry methods described above. Most importantly, the use of mechanism-based 
fluorescence transfer from acyl-ACPs ensures that any fluorescence observed on the acceptor 
module results solely from the KS active site and not from competing, nucleophilic surface 
residues within the complex protein system. 
We expect the straightforward nature of this method to permit all research labs to 
explore key features of polyketide construction. Studies ranging in scope from basic KS 
selectivity to more complex ACP/KS complementarity for designing hybrid systems will be 
greatly simplified, ultimately leading to significant advances in PKS engineering. Herein, is 
described the initial work toward designing a mechanism-based, fluorescence transfer method 
for examining substrate selectivity in PKS assemblies. 
4.2. Results and discussion 
Our previous work demonstrated that 6-deoxyerythronolide B synthase (DEBS) module 
2 ACP (ACP2) could efficiently transfer a β-lactam-derived fluorescent probe to the KS active site 
of the DEBS module 6 KSAT
19
 didomain (KSAT6).
18
 Since a careful choice of the donor ACP is 
critical for success using this technique, we decided to begin with this ACP/KS pair for proof of 
Figure 24. Panel of SNAc thioesters to probe chain-length selectivity 
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principle studies.  We had previously shown that fluorescence transfer from ACP2 to KSAT6 was 
exclusive at the active-site as no transfer occurred in the presence of the KS active site 
Fluorescence intensities for the above gel were obtained via fluorescence analysis using 
the ImageJ software. % KS acylation for each concentration of compound 1 assayed was 
calculated by subtracting the % of maximum fluorescence (determined by comparison 
to the control lane) for each band from 100%. A plot of % Acylation 
versus compound 1 concentration is shown below. 
Figure 25. Fluorescence intensity measurements for KS acylation 
(Left) Lack of fluorescence indicates near quantitative acylation of the KS active site with 
compound 1. Bright bands indicated little to no KS loading.  Lane 1 corresponds to the 
positive control where no compound 1 is added.  Numbers at the top indicate the 
concentration of compound 1 added to KSAT6.  Right figure is full PAGE gel stain. 
Figure 26. Fluorescence transfer from ACP2 to KSAT6 with variable conc. of 1 
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inhibitor cerulenin, and was complete in as little as 30 min. Encouraged by the impressive 
speed and specificity of this process, we commenced the development of a mechanism-based 
fluorescence transfer assay capable of directly probing the influence of substrate structure (i.e. 
chain length, sterics, and electronics) on KS loading.  
Based on the knowledge of biosynthestic process of DEBS, we made some initial 
hypothesis to start with. Firstly, we expected that longer chain substrates would be preferred 
based on the structure for the natural hexaketide recognized by module 6 KS.  In addition, 
module 5 incorporates a methylmalonyl-extender unit which, following elongation, is passed to 
module 6. As a result, we further hypothesized that α-branched thioesters may be particularly 
KSAT6 is pretreated with compounds 1-6.  (Left) Lack of fluorescence indicates near 
quantitative acylation of the KS active site with compound 1. Bright bands indicated little to no 
KS loading.  Lane 1 corresponds to the positive control where no acyl-SNac is added.  Numbers 
at the top indicate which compound KS was treated with prior to addition of fluorescent ACP.    
Figure 27. Fluoscence transfer from ACP2 to KSAT6 with compounds 1-6 
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well-suited for acylating the KS domain. Our fluorescence transfer method would allow us to 
readily observe these tendencies and, more importantly, provide high-resolution information as 
to their limits. 
Since PKS intermediates are of variable chain lengths at different stages of processing, 
we wished to begin by examining this simple aspect of chain length preferences for KSAT6. A 
panel of SNAc thioesters derived from straight-chain carboxylates was prepared (Figure. 24). 
Before we could begin, however, it was necessary to determine an appropriate acyl-SNAc 
concentration where subtle differences in KS-loading could be readily observed. Fluorescently 
labeled ACP was prepared as previously described by reacting holo-ACP2 with N-
propargyloxycarbonyl-β-lactam followed by Cu-catalyzed [3 + 2] cycloaddition with rhodamine 
azide (see Figure. 21).
20–22
 Excess click reagents were removed via filtration to avoid any 
complications during the assay. To determine the optimal substrate concentration for KS-
selectivity studies, compound 1 was introduced to KSAT6 at concentrations ranging from 630 
μM to 10 mM. After 1 h incubation, a slight excess, relative to KSAT6, of fluorescent ACP2 was 
added for 30 min and the protein components were subsequently separated and analyzed by 
SDS-PAGE. From these data, it was determined that the inflection point between fully loaded 
and unloaded KS corresponded to a substrate concentration of roughly 2.5 mM for compound 1 
(Figure 25.). The fluorescence intensities were analyzed using ImageJ software which shows 
trends consistent with the visual results. This analysis suggests that the visual read-out of this 
method is at least pseudo-quantitative and can be used with good confidence for comparison of 
different substrates. 
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The variable chain length SNAc compounds (1–6) were subjected to the same analysis as 
above using 2.5 mM of each. To our satisfaction, a clear preference for longer chain substrates 
was observed (Figure 27.). Given that DEBS module 6 KS normally accepts a hexaketide 
intermediate from module 5, these results are consistent with what might be expected of 
modules further down the biosynthetic assembly line. Most importantly, the observed trend 
was reproducible over multiple, separate runs (Figure. 27.). It should be noted that previous 
attempts on our part to monitor KS-loading with compounds 5 and 6 via tandem 
proteolysis/mass spectrometry were unsuccessful most likely due to precipitation of the 
acylated KS active site fragment.  
(Left) Lack of fluorescence indicates near quantitative acylation of the KS active site with 
compound 1. Bright bands indicated little to no KS loading.  Lane 1 corresponds to the positive 
control where no acyl-SNac is added.  Numbers at the top indicate which compound KS was 
treated with prior to addition of fluorescent ACP.   (Right) PAGE full gel stain 
Figure 29. Fluorescence transfer from ACP2 to KSAT6 with 7-12 
Figure 28. Panel of SNAc thioesters to probe α- and β-branching selectivity 
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We were highly encouraged from these results and were excited to examine the effects 
of more complex structural components on KS-loading. As PKS enzymes often display the ability 
to identify and distinguish α- and β-position substitutions, we were interested in uncovering any 
substrate preferences for branched alkyl-SNAc compounds. A small panel of these compounds 
was prepared with variable branching at both the α- and β-positions of the carbonyl (Figure. 28). 
Since the natural polyketide intermediate accepted by DEBS module 6 KS harbors an α-methyl 
group, it is not surprising that compounds 9, 11, and 12 appear to load KSAT6 quite efficiently 
while compounds 7 and 8 are not as effective (Figure. 29). The cyclopropyl-containing 
compound 10, however, is very interesting. Despite the presence of an α-branch, this substrate 
clearly behaves more like those without α-substituents. It is our thought that this may arise from 
the extreme cyclopropane bond angles which might alter the side chain geometry to the point 
where the KS active site does not recognize any branching. Regardless of its origins, this is a 
rather remarkable response to very subtle differences in structure between isopropyl and 
cyclopropyl groups. 
Figure 30. Panel of SNAc thioesters tp probe p-substituted aryl groups 
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Having analyzed structural aspects, we wanted to extend the idea to examine electronic 
aspects of KS-acylation.  Using a phenyl ring as a starting template we wanted to prepare a 
panel aromatic compounds bearing various electron withdrawing and donating groups to vary 
the extent of activation and deactivation, respectively.  A set of acyl-SNAc compounds was 
prepared with an assortment of p-substituents for comparison to the parent phenyl ring of 
compound 13(Figure 30). From the data, it appears that all p-substituents confer at least a slight 
reactive advantage relative to the unsubstituted phenyl ring (Figure 31). To our delight, the 
nitrophenyl compound 16 is most reactive as might be expected from the increased carbonyl 
electrophilicity offered by the electron withdrawing nature of the nitro group. Clearly, the 
electronics of the thioester play a significant role in KS acylation, but without structural 
information regarding the active site binding interactions of each of these substrates, it is 
difficult to speculate further. Taken together with the results from the chain length and 
branching studies, this method is capable of generating a wealth of information regarding KS 
selectivity in short order with minimal cost and synthetic manipulation. However, to showcase 
its maximum value for examining substrate tolerance in polyketide biosynthesis, we felt it 
(Left) Lack of fluorescence indicates near quantitative acylation of the KS active site with 
compound 1. Bright bands indicated little to no KS loading.  Lane 1 corresponds to the 
positive control where no acyl-SNac is added.  Numbers at the top indicate which compound 
KS was treated with prior to addition of fluorescent ACP.  (Right) PAGE full gel stain. 
  
Figure 31. Fluorescence transfer from ACP2 to KSAT6 with 13-18 
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appropriate to move away from didomains in favor of full PKS modules. 
To extend the scope of this method to the next level of complexity we wished to apply it 
to full module. Keeping consistent with previous data sets, we reasoned that DEBS module 6 
would be the most appropriate target for this study. This module contains a ketoreductase, acyl 
carrier protein, and thioesterase domain in addition to the KS and AT present in the didomain 
construct. The apo form of ACP was expressed and used for this study to avoid any competition 
with the native ACP of this module. In addition, the potential for fluorescence transfer from 
ACP2 to the thioesterase domain, positioned at the C-terminus of DEBS module 6, prompted us 
(Left) Lack of fluorescence indicates near quantitative acylation of the KS active site with 
compound 1. Bright bands indicated little to no KS loading.  Lane 1 corresponds to the 
positive control where no acyl-SNac is added.  Numbers at the top of each gel indicate which 
compound module 6 was treated with prior to addition of fluorescent ACP.  Overall trends in 
each gel are consistent with what was observed for KSAT6 above indicating that the 
presence of DH, ER, KR, and ACP domains does not significantly alter KS-selectivity.  (Right) 
PAGE full gel stains. 
  
Figure 32. Fluorescence transfer from ACP2 to apo-Mod6 with 1-18 
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to omit this entity from the construct used in this study. With the optimized full module in hand, 
the same 18 probes used to probe KSAT6 selectivity were applied. 
Overall, it was observed that the general trends observed for KS-selectivity in the 
didomain precisely tracked those for the intact module although the contrast between “good” 
and “bad” substrates is slightly diminished (Figure 32.). The preference for both longer chain 
and α-branched substrates is again evident and the remarkable distinction between isopropyl 
and cyclopropyl groups appears consistent. The role of electronics in KS-acylations is 
demonstrated by the observed preference for the nitrophenyl-containing compound 16 over all 
other aryl-SNAc substrates. Taken together, these results offer a clear picture of the substrate 
scope tolerated by this KS in two unique environments. The fact that the observed trends are 
consistent between the didomain and intact module provides credence to the use of “broken 
modules” for this kind of analysis and for its future applications.  
4.3. Conclusion 
We describe the development of a mechanism-based, fluorescence transfer assay for 
substrate selectivity in KS domains. It is a great application of the technique of ACP-acylation 
with β-lactams generating functional fluorescently labeled intermediates, as described in 
Chapter 3. This technique in its current form, provides a simple, qualitative output without the 
need for expensive reagents or equipment. The KS-selectivity studies are an example of the vast 
and diverse number of applications to which this method can be extended, including: (1) further 
examination of substrate attributes (i.e. stereochemistry, heteroatom incorporation, etc.), (2) 
KS/ACP complementarity, (3) determining the impact of substrate binding pocket mutations 
within KS domains on substrate tolerance, and (4) assessing the influence of active-site 
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mutagenesis on downstream KS substrate selectivity. The work described here properly lays the 
necessary groundwork toward each of these endeavors. In all, we expect this method to 
significantly aid in the study of new and existing PKS systems leading to improved understanding 
of how these extraordinary biosynthetic machines function.  
4.4. Experimental Details 
Protein expression 
ACP2 was expressed from pNW06,
8
 ACP3 was expressed from pVYA05.
19
 [KS6AT6] was 
expressed from pAYC11.
12
apo-ACPs were harvested from E. coli BL-21 and holo-ACPs were 
harvested from E. coli BAP-1.
25
 pNW06 and pVYA05 contain kanamycin resistant vectors.  
Cloning (pTL-DM6) 
Cloning of DEBS-Mod 6 (without TE domain) was done by PCR on pRSG54 (a gift from Professor 
Khosla, which encodes for DEBS Mod 6+TE). Using the primer DEBS-M6-NdeI-F1: 
TTTTTTCATATGGACCCGATCGCGATCGTCGGCATG, and DEBS-M6-HindIII-R1: 
AAAAAAAAGCTTGAGCTGCTGTCCTATGTGGTCGGC, PCR was performed in a 50 μL reaction 
mixture containing: 1 × Phusion GC buffer, 0.2 mM dNTP, 0.2 mM MgCl2, 15% Glycerol, 1 μM of 
each primer, 1 U Phusion Hot Start II DNA polymerase (Thermo scientific), and approximately 
300 ng of pRSG54 DNA. PCR amplicon of 4215 bp was obtained after 35 cycles PCR amplification. 
The DNA amplicons were excised and purified by using QIAquick Gel Extraction Kit (QIAGEN, 
Germany) and then directly subjected to double restriction enzyme digestion of NdeI and 
HindIII. The digested product was ligated to pre-digested pET-21b to obtain pTL-DM6.  
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Protein purification and isolation 
Bacteria were grown in 1 L shake cultures of LB-antibiotic media at 37 °C in an incubating shaker 
until the OD600 was between 0.6 and 0.8. Over expression was induced with 200 μL of 1 M IPTG 
(per liter of culture) and carried out at 18 °C for 18 h. After this point all work was carried out at 
4 °C. Cells were pelleted by spinning at 5000 RPM for 10 min and resuspended in 50 mL of lysis 
buffer (20 mM Tris-HCl, 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium 
pyrophosphate, 1 mM β-glycerophosphate, 1 mM sodium Na3VO4, 1 μg mL
−1
 leupeptin, pH 7.5). 
Cells were lysed using an ultrasonic converter. The lysate was pelleted at 10 000 rpm for 60 min. 
The supernatant was equilibrated with 3 mL of Ni-NTA slurry (per liter of culture) for 60 min by 
stirring with a PTFE-coated stir bar at minimal speed. The mixture was then poured into a fritted 
column and the supernatant eluted. The resin bed was washed with two 15 mL portions of wash 
buffer (50 mM phosphate, 300 mM NaCl, 20 mM imidazole, pH 8.0), and eluted with 3 mL (per 
liter of culture) of elution buffer (50 mM phosphate, 300 mM NaCl, 250 mM imidazole, pH 8.0). 
The purified protein was loaded into a 3 kDa NMW centrifugal concentrator and diluted to 15 
mL with storage buffer (100 mM Tris, 1 mM EDTA, 1 mM dithioerythritol, 10% glycerol pH 8) and 
spun until the final volume was ≤500 μL. Dilution and filtration was repeated a total of three 
times. Protein concentration was determined by Bradford assay with a BSA standard curve. 
Proteins were flash frozen and stored at −80 °C until use.  
Fluorescence transfer assay 
Unless otherwise stated, phosphate buffer refers to 100 mM, pH 7.0 phosphate. ACP2 (25 μM 
total protein) was equilibrated at ambient temperature for 15 min in phosphate buffer 
containing 2.5 mM TCEP. Poc β-lactam (10× with respect to total ACP concentration) was added 
and the mixture was equilibrated at ambient temperature for 45 min. Rhodamine Azide (2× with 
respect to Poc β-lactam), sodium ascorbate (1 mM), and copper(II) sulfate (1 mM) were added 
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to samples which had been labeled with 6. The reaction was performed at ambient temperature 
for 45 min. To remove excess Poc β-lactam and Rhodamine Azide, the mixture was loaded into a 
3 kDa NMW concentrator and the volume reduced to 100 μL by spinning in a centrifuge cooled 
to 4 °C. The mixture was diluted to 500 μL with phosphate buffer, and then concentrated to 100 
μL again. This process was repeated a total of 5 times. Protein was removed from the 
concentrator by inverting it and spinning. For transfer of the fluorescent product, [KSAT6] or the 
full module (25 μM) was pre-treated with respective SNAc (2.5 mM) derivatives for 1 h. This 
mixture was introduced to filtered acyl-ACP2 and incubated for 30 min. The [KS6AT6] and apo-
Mod6 control was executed under the same acylation and click conditions as in other samples 
but without the SNAc derivative and therefore represents full acyl transfer.  
Chromophore attachment 
The reaction was carried out at 25 μL, final concentrations reported. Rhodamine Azide, (2× with 
respect to Poc β-lactam), sodium ascorbate (1 mM), and copper(II) sulfate (1 mM) were added 
to samples which had been labeled with 6. The reaction was performed at ambient temperature 
for 45 min.  
Gel assay 
Labeled samples were diluted to 20 μL with gel-loading buffer. Proteins were separated using a 
4–20% gradient HEPES-PAGE gel (100 V, 50 mA, 70 min). Gels were developed in 10% acetic acid 
to visualize Rhodamine Azide. Labeled proteins were imaged on a UV-transilluminator. Total 
protein was stained using Coomassie stain.  
Prop-2-yn-1-yl 2-oxoazetidine-1-carboxylate: 2-Azetidinone (107 mg, 1.5 mmol) was dissolved 
in THF (7 mL) at −78 °C. LiHDMS (330 mg, 2 mmol) dissolved in THF (2 mL) was added in portions 
over 10 min and the reaction mixture was stirred for 30 min. Propargyl chloroformate (181 mg, 
1.5 mmol) dissolved in THF (2 mL) was added in portions over 10 min and the reaction mixture 
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was stirred at −78 °C for 2 h then allowed to warm to ambient temperature. The reaction 
mixture was diluted with water and extracted with DCM (50 mL × 3). The combined organic 
layers were washed with brine and dried over Na2SO4. Solvent was removed by rotary 
evaporation. Purification of crude product by flash chromatography with 95 : 5 DCM–Methanol 
yields (106 mg, 0.69 mmol) 46% of product as pale yellow solid.  
Sulforhodamine-B azide: 3-Azido-1-aminopropane
23
 (22 mg, 0.22 mmol) and triethylamine (51 
mg, 0.5 mmol) were dissolved in 1 mL of 5 : 1 DCM–DMF and cooled to 0 °C. Sulforhodamine B 
sulfonyl chloride [mixture of ortho- and para-sulfonyl chloride isomers] (115 mg, 0.20 mmol) 
was added portion-wise over ca. 30 min and stirred overnight at room temperature. Solvent was 
removed in vacuo, and the product was purified by flash chromatography over silica gel with 90
: 5 : 5 DCM–Acetonitrile–Methanol mobile phase. The ortho isomer was distinguished by its 
reversible color change in pH 9.0 buffer.
24
Para isomer: (22 mg 0.034 mmol) 17%, ortho isomer 
(18 mg, 0.028 mmol) 14%. Both obtained as a red solid with a metallic green luster. The ortho 
isomer was found to perform best in the click reaction and was utilized for labeling experiments.  
General method for preparation of all N-acetylcysteamine (SNAc) thioester derivatives 
To a solution of triethylamine (2.80 mmol) in dichloromethane (10 mL) was added the 
appropriate acid (1.40 mmol), (3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (1.40 
mmol), 1-hydroxybenzotriazole (HOBt) (1.40 mmol) and N-acetylcysteamine (SNAc) (1.35 mmol) 
under argon. The reaction mixture was stirred overnight. The organic layer was washed with 
saturated NaHCO3 solution, 0.1 N HCl solution and brine. It was then dried over anhydrous 
sodium sulfate, concentrated under vacuum, and purified by flash column to provide the final 
product in pure form. 
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CHAPTER 5 
EXAMINING KS SELECTIVITY IN FLUVIRUCIN B1 SYNTHASE 
5.1 Introduction 
Over the past several decades, researchers have devised numerous methods for 
manipulating PKS processes in an effort to diversify product structure and, ultimately, biological 
activity.
1-5
  In the effort to capture the true engineering potential of PKSs, numerous techniques 
have been explored for separation, fusion, and rearrangement of component enzymes.  
The domain swapping technique involves physically replacing an individual PKS enzyme 
with one from another synthase. Most commonly used for AT domains, the key to effective 
domain swapping is comprehensive knowledge of domain boundaries such that the surrounding 
enzymes are unaffected. The primary downside to this procedure is that heterologous domains 
often behave differently in their new environment.  The domain addition technique is generally 
employed when an increase in enzyme activity is desired. Many attempts have been made to 
incorporate KR, DH, and ER domains into modules where they are absent but the most effective 
strategy for domain addition involves replacing the entire module with a heterologous one 
bearing the appropriate tailoring domains. Although some success has been realized with these 
techniques, decreased yields of engineered products have limited their scope and efficacy. In 
both cases, introduction of heterologous enzyme components often leads to disruption of 
three-dimensional structure and causes protein communication issues between native and 
heterologous components, often impeding the flow of intermediates within and between 
modules. These factors together contribute to the issue of decreased yields.
6-11 
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The simplest technique of all is the domain deletion/inactivation, functionally the 
opposite of domain addition. The activity of any module containing at least one tailoring domain 
(KR, DH, or ER) can be altered via mutation of active site residues or removal of the entire 
enzyme. It has been shown, however, that mutation (inactivation) provides significantly higher 
product yields compared to removal (deletion), owing largely to the fact that the former method 
maintains the native three-dimensional structure of the engineered module. This observation 
together with the domain addition and swapping data, form the initial motivation and basis of 
our hypothesis. We were convinced that disruption of PKS structure and recognition motifs 
plays a significant role in diminished product yields. 
 For modular polyketide synthases this means unearthing assemblies which bear the full 
complement of tailoring domains (KR, DH, and ER), similar to mammalian FAS, in most, if not all, 
active modules.  In contrast to current methods, carefully executed mutagenesis of key native 
active site residues should result in all possible β-functionalities. The key advantage will be the 
ability of leaving the native protein-protein interactions intact (Figure 33).  Therefore, we were 
particularly interested in PKSs that produce largely unfunctionalized polyketides (i.e. methylenes 
at most β -positions) and may provide optimal engineering potential.  
Our lab has recently identified the gene cluster for a modular PKS responsible for the 
production of fluvirucin B1 in Actinomadura vulgaris (Figure 34.).
12-14
Fluvirucin B1 is a 14-
membered macrolactam with moderate to good antifungal and antiviral activities. It is an 
interesting PKS system with many unique biosynthesis attributes. It contains 5 modules of which 
4 contain the full set of PKS tailoring domains. According to our hypothesis, it is an ideal system 
for engineering strategy of single domain inactivation via site-directed mutagenesis. 
We were motivated to explore the biosynthetic origin of fluvirucin B1 with the ultimate 
goal of providing a platform for polyketide engineering that circumvented the need for 
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incorporation of heterologous domains to achieve maximal product diversity.  By using the 
strategy of active-site mutagenesis, we can inactivate one enzyme at a time to access all the β -
functionalities possible (Figure 33.). The fluvirucin polyketide synthase offers nearly double the 
product scope of the most commonly used assembly, 6-deoxyerythronolide B synthase, due to 
the significantly increased number of ketoreductase, dehydratase, and enoyl reductase domains 
within the cluster. By using this approach, there is a potential to produce large library of 
macrolactam variants. Such a system provides an ideal platform for conducting various kinds of 
PKS investigations with the current set of β-lactam based molecular tools that we have 
successfully developed. 
The lack of additional ring functionalities caught our interest as we hypothesized that 
nearly all active modules should contain the FAS-like domain organization where KR, DH, and ER 
are all present. That is another interesting feature of this PKS system in terms of resemblance to 
FASs. If one were to consider PKS systems as evolutionarily connected to FAS, the fluvirucin 
synthase may represent an early link between the two.  These investigations of their 
biosynthetic mechanisms can help shed some light on this aspect as well.  
 
Role of substrate selectivity 
 
Novel compound production by designing alterations in chemical structure at the genetic level. 
Figure 33. Schematic for mutational inactivation strategy of fatty acid-like PKS modules 
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Flow of intermediates along a PKS system heavily relies on communication between 
neighboring enzymes). Many groups have focused on determining the associated recognition 
motifs that govern these interactions.
15-17
 However, we were interested in obtaining product 
diversity without reinventing enzyme architecture and work with what nature has already 
provided. To do so, a strategy where product diversification is solely the result of domain 
inactivation must be implemented. Without disturbing the protein-protein interactions by 
leaving all recognition interfaces in their natural forms, the problem of producing and shuttling 
intermediates along the synthase will now be reduced to one of substrate selectivity. Above all, 
it will rely on the ability of downstream KS to accept modified intermediate substrate handed 
down by an upstream mutant module. 
Instead of using radiolabelled substrates that would require elongation and cyclization 
events or struggle with LC/MS to tease out differences in small molecular masses of the highly 
similar intermediates, it occurred to us that the mechanism-based fluorescence transfer assay to 
investigate KS selectivity as described in Chapter 4 could be of great assistance for this purpose 
18
. Firstly, we prepare a library of potential substrates with β-functional modifications for each of 
the KSs and use them to assay KS compatibility for these novel β-carbon analogues that they 
would encounter during biosynthesis in a modified, mutant module. In this manner, this assay 
can be used as a prototype that mimics substrate transfer and intermediate flow to test the 
effectiveness of the mutagenesis in the module. In addition to delivering improved yields of 
engineered products, such a system will, for the first time, provide a systematic means of 
assessing the relative contribution of substrate selectivity to the flow of structures from one 
module to the next in full-length PKS. 
The ultimate test of this methodology is to combine high yielding single mutants to build 
increased complexity and diversity in polyketide structure by using a multiple-plasmid system to 
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incorporate more than one mutation.  In which case, the KS-selectivity assay can be employed to 
gain insight regarding behavior of downstream enzyme to a particular upstream structural 
modification caused by a mutation in an intact PKS and consequently help in logical designing of 
these complex assemblies. In this manner, our primarily goal is to use this KS-selectivity assay as 
a tool to lay the groundwork to ensure success of the product diversification strategies. But in 
turn, this will provide a wealth of information regarding influence of upstream modifications on 
downstream enzyme activity and help improve our understanding of the biosynthetic machinery 
and its working. 
5.2. Results and discussions 
From the core structure of fluvirucin B1, we hypothesized that the producing PKS would 
consist of five extender modules assuming that a β-alanine derivative is used as a starter unit in 
the process.  The sole hydroxyl group would therefore arise from a module harboring only a KR 
domain while all other extender modules would contain the full complement of KR, DH, and ER 
domains (Figure 34.).  Based on the positions of macrolactam ring substituents, we expected 
that: (1) the first and last modules contained ethylmalonyl-specific AT domains, (2) the second 
and fourth modules incorporated malonyl groups, and (3) the third module utilized 
methylmalonate (Figure 34.).  Finally, ring closure was most likely achieved via a C-terminal 
thioesterase (TE) domain as is the case with similar macrocyclic polyketides.
19-21
 To test these 
hypotheses and determine the precise arrangement of enzymes within the assembly, we set out 
to identify and characterize the fluvirucin B1 biosynthetic gene cluster.     
 To do so, the producing organism, Actinomadura vulgaris, was cultured following 
published procedures.
13-15
 Genomic DNA was isolated and sequenced affording 436,311 
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overlapping sequence fragments.  These sequences were partially assembled resulting in 444 
consensus sequences ranging in size from 5000 to 170,000 base pairs.  The relatively large size 
of PKS constructs allowed us to quickly identify potential hits by searching each assembled 
sequence for open reading frames of at least 4000 base pairs.  Our search identified several PKS 
gene clusters, one of which contained the expected size and module composition of the 
proposed fluvirucin PKS. 
Three modular PKS genes, flu A-C, were found to contain an arrangement and 
composition of domains consistent with the expected fluvirucin PKS assembly
22
 (Figure 34.).  
FluA contains modules 1 and 2 of the fluvirucin B1 assembly. As expected, module 1 has the full 
compliment of tailoring domains (KR, DH, and ER) while module 2 possesses only a KR domain 
putatively leading to the sole hydroxyl group on the macrolactam ring.  A single loading ACP is 
found at the N-terminus of FluA similar to the vicenistatin PKS which utilizes a β -methyl- β -
alanine starter unit.
23 
FluB contains modules 3 and 4 of the fluvirucin B1 PKS.  Both modules 
contain KR, DH, and ER domains as would be predicted from the fluvirucin core structure.  
Finally, FluC consists of module 5 and a C-terminal TE domain.  Module 5 again has all three 
tailoring domains consistent with the lack of functionality at the corresponding macrolactam 
ring position.   
Fluvirucin B1 PKS Genes  
As predicted, the fluvirucin B1 polyketide synthase consists of 5 extender modules 
flanked by an N-terminal loading ACP and C-terminal TE domain.  All but one of the extender 
modules contains a KR, DH, and ER domain in addition to the required KS, AT, and ACP leading 
to the relatively unfunctionalized nature of the macrolactam product.  Based on this 
arrangement of composition of modules, β-alanine is expected to serve as the starter unit for 
fluvirucin B1 biosynthesis. 
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AT Selectivities 
Extender unit selectivity for AT domains provides compelling evidence for any link between a 
given PKS assembly and its associated polyketide product.  Using, the SEARCHPKS program 
developed by Mohanty and coworkers, probable coenzyme A substrates were determined for 
each of the five putative fluvirucin B1 synthase AT domains.
24
  To our delight, all of the predicted 
AT domain specificities were consistent with the fluvirucin B1 core structure. Specifically, 
modules 2 and 4 showed high sequence similarity with malonyl-specific AT domains while 
module 3 was predicted to utilize methylmalonyl-CoA.  Modules 1 and 5 returned a single hit for 
ethylmalonate specificity amidst several methylmalonyl-specific AT domains.  This is most likely 
due to the considerably lower abundance of ethylmalonyl-specific ATs relative to 
methylmalonyl-specific ones rather than a true indication of relaxed specificity.   
 
The assembly consists of five extender modules flanked by an N-terminal loading ACP and C-
terminal thioesterase (TE) domain. FluA consists of the loading ACP, module 1 and module 2. 
FluB consists of modules 3 and 4. FluC consists of module 5 and the TE domain.   
Figure 34. The putative fluvirucin B1 PKS 
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a) Schematic diagram of AT substrate selectivity studies of modules 1, 3, and 5 b) 
representative LC-MS analysis of FluAT3 loading c) Results of AT studies, red checks indicate 
that the substrate shown on the left is transferred from the indicated AT to the ACP domain, 
whereas a black X indicates that no substrate transfer was observed. FluATX = fluvirucin AT 
domain from module X 
Figure 35. FluAT specificity studies 
b)  FluAT3 substrate selectivity 
c) 
a) 
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 In order to examine the AT specificities, the N-acetylcysteamine(SNAc) analogues of 
ethylmalonyl-CoA, methylmalonyl-CoA and malonyl-CoA were prepared.  The ATs from Moduke 
1, 3 and 5 were each tested for their ability to load their cognate ACP with these three SNAc 
compounds (Figure 35.). The ACP modification was observed by LC-MS as described previously. 
To our delight, as expected from the sequence similarity studies, AT1 and AT5 loaded 
ethlymalonyl product and AT3 loaded methylmalonyl product. These observations about the 
unusual substrate preferences further give credence to the enzyme identities. 
Flu KS substrate selectivity 
As outlined earlier, upon characterization of this unique PKS system, our aim was to test 
the tolerance of KSs by applying the technique developed and described in Chapters 3 and 4.  
This method will assess the KS selectivities towards a range of altered β-functionalities with its 
original substrate motif as reference. An appropriate acyl carrier protein will be chosen to 
generate a β-lactam based fluorescent acyl-ACP to act as a donor in this process. By tracking the 
extent of fluorescence transfer by the ACP to the KS active-site, we can assess the extent of KS 
loading by each of the test substrates. Such a straightforward analysis will provide key insight 
into KS preferences for different β-carbon bearing intermediates as well as shed light about the 
KS preferences compared to other KSs in the same PKS. All these trends and observation would 
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Figure 36. Panel of substrates for KS Module 3 of Fluvirucin B1 synthase 
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be of great value in learning about the preferences and functioning of key enzymes of this novel 
PKS system for which no prior information is available. 
For a preliminary screen, we prepared a small panel of SNAc thioesters (Figure 36.). 
They incorporate different variations of hydroxyl, enoyl and fully reduced carbon at the beta 
position. This panel is a good starting point to investigate the preferences of KS for variation of 
functionalities at the beta position and be used further as a framework for testing the other four 
KSs in this PKS system.  These preliminary experiments will provide some insight into the extent 
and contrasts of tolerance exhibited by these different KSs. To begin with, we started with the 
KS of module 3. We conducted a few experiments with buytryl analogues, namely: (R)and (S)-
hydroxyl at  β-position.  
As predicted from its biosynthesis flow chart, it accepts a substrate with an (S)-hydroxyl 
group at its β position whereas the other stereoisomer loads the KS active site poorly resulting 
in substantial fluorescence transfer(Figure 37.). There results have been confirmed by LC-MS 
experiments where FluKSAT3 is incubated with both the stereoisomers and KS active site 
modification is analyzed by mass spectrometry (Figure 38.).  
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Figure 37. Fluorescence transfer from ACP3 to FluKSAT3  
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5.3. Conclusions 
In summary, we have identified and characterized the putative PKS genes associated 
with fluvirucin B1 aglycone biosynthesis in A. vulgaris.  The number and composition of modules 
as well as predicted AT specificities are consistent with the fluvirucin B1 structure.  The 
abundance of tailoring domains within the assembly is expected to provide increased 
engineering potential, through straightforward active site mutagenesis.  The assay developed 
with β-lactams derived functional acyl-ACPs for examining KS-selectivity is being applied to 
fluviricin KSs to understand effects of introducing novel β-functionalities on downstream KSs in 
terms of substrate preferences.  Some preliminary work has been done with Flu KSAT3 to ensure 
feasibility and reproducibility and work is underway to expand the application to all the Flu KSs.  
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Table 4. KSAT3 loading with 3-hydroxy-butyric-SNAc 
Protein Probe Mass expected(m/z, z=+2) 
KSAT3 - 1667.6 
KSAT3 3-hydroxy-butyric-SNAc 1710.1 
 
 
LC–MS data for module 3 KS-acylation with (R)-3-hydroxybutyryl-SNAc (top) and (S)-3-
hydroxybutyryl-SNAc (bottom). Only the (S)-isomer is accepted by module 3 KS as is 
expected from the fluvirucin B1 structure. Peaks are labeled with the corresponding 
acylated or unacylated KSAT3 didomain. All peaks are m/z = +2. Table below shows the 
masses for loading of KS active-site. 
Figure 38. LC-MS loading experiments of Flu KS 
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5.4. Experimental Details 
General method for preparation of all N-acetylcysteamine (SNAc) thioester derivatives  
To a solution of triethylamine (2.80 mmol) in dichloromethane (10 mL) was added the 
appropriate acid (1.40 mmol), (3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (1.40 
mmol), 1-hydroxybenzotriazole (HOBt) (1.40 mmol) and N-acetylcysteamine (SNAc) (1.35 mmol) 
under argon. The reaction mixture was stirred overnight. The organic layer was washed with 
saturated NaHCO3 solution, 0.1 N HCl solution and brine. It was then dried over anhydrous 
sodium sulfate, concentrated under vacuum, and purified by flash column to provide the final 
product in pure form. 
Fluorescence transfer assay 
Unless otherwise stated, phosphate buffer refers to 100 mM, pH 7.0 phosphate. ACP2 (25 μM 
total protein) was equilibrated at ambient temperature for 15 min in phosphate buffer 
containing 2.5 mM TCEP. Poc β-lactam (10× with respect to total ACP concentration) was added 
and the mixture was equilibrated at ambient temperature for 45 min. Rhodamine Azide (2× with 
respect to Poc β-lactam), sodium ascorbate (1 mM), and copper(II) sulfate (1 mM) were added 
to samples which had been labeled with 6. The reaction was performed at ambient temperature 
for 45 min. To remove excess Poc β-lactam and Rhodamine Azide, the mixture was loaded into a 
3 kDa NMW concentrator and the volume reduced to 100 μL by spinning in a centrifuge cooled 
to 4 °C. The mixture was diluted to 500 μL with phosphate buffer, and then concentrated to 100 
μL again. This process was repeated a total of 5 times. Protein was removed from the 
concentrator by inverting it and spinning. For transfer of the fluorescent product, [KSAT3] was 
pre-treated with respective SNAc (2.5 mM) derivatives for 1 h. This mixture was introduced to 
filtered acyl-ACP2 and incubated for 30 min. The [KSAT3] control was executed under the same 
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acylation and click conditions as in other samples but without the SNAc derivative and therefore 
represents full acyl transfer.  
Chromophore attachment 
The reaction was carried out at 25 μL, final concentrations reported. Rhodamine Azide, (2× with 
respect to Poc β-lactam), sodium ascorbate (1 mM), and copper(II) sulfate (1 mM) were added 
to samples which had been labeled with 6. The reaction was performed at ambient temperature 
for 45 min.  
Gel assay 
Labeled samples were diluted to 20 μL with gel-loading buffer. Proteins were separated using a 
4–20% gradient HEPES-PAGE gel (100 V, 50 mA, 70 min). Gels were developed in 10% acetic acid 
to visualize Rhodamine Azide. Labeled proteins were imaged on a UV-transilluminator. Total 
protein was stained using Coomassie stain.  
ACP acylation by AT 
To a mixture of  ACP (50 µM) and KS-AT (2 µM) in 100mM pH 7.0 phosphate buffer (50 µL total 
volume) containing 2.5 mM TCEP  at 4
 o
C was added appropriate SNAc thioester substrate (500 
µM) . The mixture was incubated 4 
o
C for 30 min to achieve AT assisted acylation of the ACP. 
Sequence grade modified trypsin was added to prepare samples with final ration trypsin:ACP to 
be 1:10 (w/w). The mixture was incubated for 60 min at 37 
o
C.  Digestion was quenched by 
addition of equal volume of 10% formic acid. Digests were stored at -80 
o
C until analysis. 
KSAT3 loading 
To a mixture of KSAT3 (25 μM) in 100 mM pH 7.0 phosphate buffer (50 μL total volume) 
containing 2.5 mM TCEP at 4 
o
C was added appropriate SNAc thioester substrate (5mM). The 
mixture was incubated at  4
o
C for 60 min to achieve KS acylation. Sequence grade modified 
trypsin was added to prepare samples with final ratio trypsin:ACP to be 1:10 (w/w). The mixture 
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was incubated for 60 min at 37 
o
C. Digestion was quenched by addition of equal volume of 10% 
formic acid. Digests were stored at -80 
o
C until analysis. 
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CHAPTER 6 
SUMMARY AND FUTURE DIRECTIONS 
 Small molecule probes in the form of reactive heterocycles  have been developed for 
direct acylation of ACP in polyketide synthases. These probes are in the form of β-lactones and 
β-lactams have been optimized to specifically target ACP Ppant thiol and introduce polyketide-
like functionalities onto the ACP for further investigations. These reactive heterocycles have 
been used to introduce affinity and labeling groups onto crucial enzymes of the PKS enabling 
investigation of PKS biosynthesis processes. 
 In the first chapter, we introduced the field of polyketides and their scope and 
importance as therapeutics. We introduced the major traditional methods of examining PKSs 
and their shortcomings which have restricted the efforts in novel polyketide engineering.  We 
also introduce our hypothesis described in detail in rest of the thesis for developing a novel 
approach using small molecules for examining PKS biosynthesis. 
The second chapter describes use of functionalized β-lactones to achieve direct 
acylation of ACP. It provides a greatly simplified alternative to achieve direct, selective acylation 
of holo-ACP using readily accessible β-lactones as electrophilic partners for the PPant thiol. It 
offers a synthetically straightforward means of loading key PKS components with novel 
substrates.  
The third chapter describes the introduction of novel β-lactam-based probes as versatile 
reagents for ACP labeling as a substantial improvement over previously described β-lactones.  
An versatile alkyne group is introduced to provide a handle for conjugation to fluorophores and 
affinity labels. The utility of these probes for mechanistic interrogation of polyketide 
biosynthesis is demonstrated by comparison to traditional probes.   
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In the fourth chapter we describe the application of β-lactam probes for designing a 
mechanism-based fluorescent assay for examining KS selectivity. The KS of DEBS module 6 is 
examined for its ability to accept a variety of simple thioesters and some remarkable 
observations are made. This technique demonstrates its utility by providing a simple, qualitative 
output without need for expensive reagents.  Chapter five describes the application of the assay 
for examining KS selectivity to a new PKS system, Fluvirucin B1 synthase. This assay is set-up to 
examine selectivities of KSs from this PKS towards a panel of β-functionalities to guide the 
efforts of performing active-site mutagenesis in modules to produce novel polyketide products.  
 The fifth chapter extends the utility of this reactive heterocylce small molecule based 
approach to examine KS selectivity in a novel PKS system. The Fluvirucin B1 synthase has been 
cloned out and characterized to be used as platform for producing novel Fluvirucin B1 analogues 
using an active-site mutagenesis strategy. In the absence of protein-protein interaction effects, 
substrate selectivity is the key factor determining proper intermediate flow in these engineered 
systems. The KS substrate selectivity of downstream enzymes has been planned to test the 
feasibility of the mutagenesis strategy and determine the role of substrate selectivity. The 
FluKSAT3 has been analyzed using this method demonstrating its ability to provide a simple 
visual readout for the KS substrate preferences.   
These preliminary studies lay a good groundwork for further extensive KS substrate 
analysis. The FluKSAT3 analysis concept will be extended to all the remaining four KSs starting 
with analysis of their native substrate preferences and extending it into non-native substrates 
with variable β-functionalities. The information gathered about substrate preferences of all the 
KSs will map out the possibilities in terms of engineering novel Fluvirucin analogues. The 
availability of this critical information about KS preferences will help design of active-site 
mutagenesis strategies with increased confidence in the execution of this scheme. Rather than 
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embarking upon a strategy with no prior information about the enzyme selectivity, the vital 
information about KS substrate preferences will definitely improve the success rate of producing 
diversified and novel polyketide analogues of Fluvirucin and other known and new PKS systems 
for therapeutic applications. 
Another interesting application of this method could be examining the impact of 
substrate binding pocket mutations within KS domains on substrate tolerance. To begin with, 
crystal structures of the KS binding-site pocket will be examined and combined with homology 
studies to identify some potential amino acids involve in key interactions with substrates. 
Systematic mutations of these potential residues in the binding pocket of the KS can be 
performed to identify actual residues responsible for substrate preferences displayed by the KS. 
A series of KS mutant didomains as well as full modules will be prepared and analyzed against 
various substrates by using fluorescence transfer assay. By means of a simple visual read-out, 
this fluorescence assay can easily pick out KS mutants that display altered substrate tolerance 
and in turn identify the residue that has undergone mutation/alteration. Overall, PKS 
engineering efforts often suffer from poor yields due to lack of information about enzyme 
preferences. By identifying key residues in KS that determine substrate tolerance, these residues 
can be manipulated to alter substrate tolerance as necessary and greatly help PKS engineering 
efforts by improving yields in new and re-engineered systems.  
A great advantage of this assay is that due its flexibility, simple set-up with quick visual 
read-out, it can be easily adapted to a medium/high-throughput kind of application where any 
KS in question can be rapidly assessed against a large panel of natural and non-natural 
substrates. This incredible feature will undoubtedly make it a popular choice for use in 
performing polyketide engineering to make novel polyketide products. We expect that the 
successful application of this approach will provide researchers a reliable tool to overcome the 
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challenge posed by strict enzyme selectivity and pave way to an era of highly simplified and 
productive PKS engineering. 
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